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Zusammenfassung 
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Zusammenfassung 
Das kaum erforschte Gebiet der Knorpelremodellierung wurde in dieser Dissertation noch 
einmal genauer untersucht. Jahrelang wurde angenommen, Gelenkknorpel und fetaler 
Wachstumsfugenknorpel würden gleichermassen agieren, was bedeutet, dass 
Knorpelzellen in der kalzifizierten Zone des Gelenkknorpels hypertroph und apoptotisch 
sind. Auch ein physiologischer Remodellierungsprozess des intakten Knorpelgewebes 
durch Zellen aus dem subchondralen Knochen wurde nicht für möglich gehalten. Allzu 
oft wurde Knochen und Knorpel separat betrachtet, obwohl sie denselben embryonalen 
Ursprung haben. 
Ziel dieser Arbeit war es, die Vitalität und Migrationsfähigkeiten von Zellen aus dem 
subchondralen Knochen in den darüber liegenden hyalinen Gelenksknorpel zu 
beobachten. Mit Hilfe einer osteochondralen Explantatkultur gelang es mit speziellen 
Lebendfärbungen, die unter anderem auch Veränderungen des Aktinskeletts deutlich 
machten, die einzelnen Zellen über einen definierten Zeitraum mittels Zeitraffer in einem 
CLSM (Confocal Laser Scanning Microscope) darzustellen und zu verfolgen. Die 
Migration der Zellen konnte im physiologischen sowie im pathophysiologischen Zustand 
mit, bzw. ohne Einwirkung von Entzündungsfaktoren, in vitro demonstriert werden.  
Dies beweist, dass subchondraler Knochen und Gelenkknorpel als Einheit betrachtet 
werden sollten und dass eine Remodellierung in diesem Gewebe durchaus möglich ist. 
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Summary 
The scarcely researched field of cartilage remodeling was examined in detail in this thesis. 
For years, it was thought that cartilage in joints behaves the same way as cartilage of the 
growth plate, which means that cells in the calcified zone of articular cartilage are 
hypertrophic and apoptotic. Also, a physiological remodeling process of the intact 
cartilaginous tissue, through cells from the subchondral bone, was not considered 
possible. Often bone and cartilage are contemplated separately, although they have the 
same embryonic origin.  
The aim of this work was to check on the viability of cells and to detect migration of cells 
from the subchondral bone into the overlying hyaline articular cartilage by developing a 
method to image labelled cells within cultured osteochondral explants. 
By using an osteochondral explant culture, the individual cells could be supervised and 
tracked in a CLSM (Confocal Laser Scanning Microscope) over a certain time period 
(time-lapse recording) using special live protein stains, which also showed changes in the 
actin skeleton. The migration of the cells was shown in vitro in homeostasis as well as in 
pathophysiological state, with and without the influence of inflammatory factors. 
This proves that subchondral bone and articular cartilage should be viewed as a unit and 
that a remodeling in this tissue is possible. 
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1 Introduction 
1.1 Purpose of dissertation 
Remodeling means breaking down existing tissue and rebuilding it, either as a tissue of 
similar or even better value. In case of repair, the broken-down tissue is replaced with 
tissue of minor quality. This process does not only take place as a result of damage, but 
also takes place during homeostasis, to keep the tissue intact and maintain it.  
Most tissues in the body have the ability to remodel, except for articular hyaline cartilage, 
where this was never demonstrated. This fact makes one wonder why this is not supposed 
to also be the case in articular cartilage. Inflammation, granulation, reparation and 
remodeling are the basic phases of healing in the body. One would assume that this should 
also be possible in cartilage.  
The greatest difference in comparison to all other tissues is, that articular cartilage is free 
of blood vessels and a-lymphatic. How do molecules manage to get where they are 
needed, without blood? Along that line, the physiological remodeling mechanisms of the 
articular hyaline cartilage matrix over time is also still not clearly understood, although 
enzymes degrading the matrix have been identified. Additionally, there is no clarity about 
the life expectancy of cartilage cells, so-called chondrocytes, and/or whether 
chondrocytes can migrate or stay at their set location within the matrix throughout their 
viable phase. 
It also is not fully understood yet, which physiological mechanisms – or molecular cross 
talks are ongoing between subchondral bone and articular hyaline cartilage. In fact, there 
is a common belief, that subchondral bone and overlying cartilage are separate structures 
in adult life, although we know the connections between these during fetal development 
and during growth of the skeleton post-partum. This assumption is questioned in this 
study, since biologically this complete separation in adult life does not make real sense. 
It starts with the fact, that cells are commonly observed within the calcified cartilage zone 
in normal cartilage. In addition, “cutting cones” reaching from the subchondral bone into 
the calcified cartilage zone, similar to the ones in bone remodeling, are commonly 
visualized in healthy and osteoarthritic cartilage. Therefore, it is of enormous importance 
to study subchondral bone and the hyaline cartilage as a biological unit, also on behalf of 
the remodeling process. If the subchondral bone is damaged, for example, it will always 
also cause a breakdown of the overlying cartilage. The other way around a cartilage defect 
also always causes a change in subchondral bone2-4. This makes sense, also due to the fact 
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that subchondral bone is provided with vasculature that is thought to nourish also the 
deepest zones of the cartilage through diffusion. Besides the molecules coming from the 
synovia, that reach the cartilage through diffusion and load, it seems like the only other 
way of receiving information or signals is from the subchondral bone. Still, there must be 
a chance for cartilage to remodel from either the cartilage-side and/or the subchondral 
bone plate. Possibly, progenitor cells make their way through subchondral bone into the 
cartilage as this occurs in full cartilage lesions. Possibly, it could also be that these cells 
differentiate into mature chondrocytes and migrate further within the extracellular 
matrix? And if so, which factors cause and/or accelerate this process? Looking at 
cytokines causing osteoarthritis, it could well be that these or similar factors could initiate 
a migration process of the progenitor cells, respectively chondrocytes in articular cartilage 
from either the subchondral bone to cartilage or from the cartilage surface towards the 
deeper matrix or even to the subchondral bone. 
The aim of this thesis was to demonstrate migration mechanisms as part of the normal 
physiological remodeling process between the subchondral bone and overlying hyaline 
articular cartilage. It was based on the hypothesis that the cells in the calcified cartilage 
layer are not hypertrophic, but very much alive and capable of proliferating and/or 
migrating through the tissue to maintain the cartilage. We also believe, that progenitor 
cells are constantly supplied by the subchondral bone and migrate through the calcified 
cartilage zone and the tide mark upwards into the cartilage matrix, where they continue 
to migrate to the cartilage surface along the collagen fiber network as part of the normal 
physiologic remodeling process.  
Showing the migration of cells within the subchondral bone and cartilage unit was 
difficult, not only due to the lack of known technologies in literature of this field. 
Technical limitations of finding the right way to fix a live sample under the microscope 
and then penetrate it from either the cartilage or the bone-side or both, over a long time- 
period in a time-lapse microscope, while keeping the tissue alive, were a real challenge.  
2 Literature Survey 
2.1 Animals 
Compared to other domesticated large animals, sheep are quite accepted as research 
animals in society. They are easy to handle, behave very docile, are not aggressive and 
lower in cost than horses for example. It is easy to keep sheep in nearly perfect natural 
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conditions, which makes it more acceptable ethically and ethologically. They are flock 
animals and need to be kept with one or more companions. Sheep feel best outdoors with 
hardly any supervision. Because of the easy management of sheep, the costs for housing 
and pasture can be kept very low. There is a big variety in breed through having different 
use for sheep. Wool, milk and meat production cause a biological and/or genetic 
diversity5.   
In this case, sheep were also easy to access because they were used for many different 
other studies6-10 at the Musculoskeletal Research Unit, Zurich.  
The size of the sheep`s humeral head easily allowed me to collect a great amount of 
samples out of just one front limb, which reduced my need of animals and also 
compounds the benefit of large animals.  
Although the general thickness of, for example, a horse’s cartilage is almost equal to the 
general thickness of human cartilage, the horses` calcified layer is greater11 compared to 
the ones of sheep. Because the focus is on the calcified layer in this study, it is of great 
importance to have an animal model similar to humans. Still it is more acceptable to 
society to use sheep as research animals, because they are “food animals” and humans 
have a lower emotional attachment to sheep, than to companion animals12. Also, there are 
no evolutionary reasons, why cartilage of sheep should heal differently to other species, 
like humans, in fact their morphology is very similar. 
Rodents for sure, financially would be a better solution. Compared to all other animals 
their epiphyses retain open with continued enchondral ossification a life-long though. 
Besides that, the movement characteristics are very different from human beings, which 
changes their load pattern on the cartilage. Another disadvantage of rodents is, that the 
joint size obviously is way smaller than in large animals and the cartilage layer is very 
thin. Different from humans and sheep, cartilage heals intrinsic spontaneously in rodents. 
Even though financial aspects and public acceptance of ethical aspects have to be 
considered, large animal models address a lot of the limitations, which are linked to rodent 
models. Large animals are required for translational research, which is supposed to be 
used in human clinical trials, and are compulsory for the regulatory approval of cartilage 
repair strategies. More important than the size of animals is the maturity of the cartilage 
itself according to the ICRS (International Cartilage Repair Society). Mature cartilage 
ensures that biochemical, biomechanical and cellular healing characteristics are 
appropriate for human clinical application.13 
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The sheep that were used for this study were all female and aged between 2-3 years. 
Immediately after arrival from the farm (Staffelegghof, 5024 Küttigen, Switzerland), the 
sheep were examined by a veterinarian and adjudged as non-pregnant and free from 
disease. All research animals were maintained in good health.  
2.2 Articular Cartilage 
Cartilage in synovial joints is so-called hyaline cartilage. It is the most common cartilage 
in the body. Not only in joints, but also rib cartilage, as well as nasal cartilage and the 
cartilage rings in the trachea and the bronchial tubes consist of hyaline cartilage. Its name 
comes from the bluish color it has in early age. Hyaline cartilage has two known ways of 
growth. It grows from the inside through matrix synthesis (interstitial growth) and, in case 
of non-articular cartilage, from the outside through the perichondrium (appositional 
growth). It is said that mature cartilage stops its appositional growth and only carries on, 
in case of an injury. 
Hyaline cartilage in general is covered with the perichondrium, which has two layers. The 
top layer, called stratum fibrosum, which helps to distribute the shear forces, the stratum 
chondrogenicum follows, which helps to regenerate the cartilage with its mesenchymal 
cells. The perichondrium is supplied with blood vessels that provide the cartilage with 
nutrients through diffusion. In joints, the perichondrium is only left at the transition from 
periosteum to the cartilage region, but there is no perichondrium covering the hyaline 
cartilage on the articular surface. Here, the hyaline cartilage is not supplied with blood, 
but gets its nutrients through diffusion out of the synovial fluid14.  
2.2.1 Cells 
Compared to other tissues in the body, the metabolic activity of cartilage is very low15. 
The cartilage varies in thickness, depending on the location, the species and the type of 
joint. In most cases, it is in humans between 1-5 mm thick, in sheep thickness is between 
0.3 – 0.9mm (own measurements). The only cells found in articular cartilage so far, are 
called chondrocytes, which only make up 1% of the articular cartilage volume in human 
adults16. 
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2.2.1.1 Chondrocytes 
Chondrocytes are usually shaped round. Depending on their location (zone) they also 
appear ellipsoid or flattened17. Chondrocytes lie in so-called chondrones, which include 
not only the cell itself but also its surrounding environment (described in 2.2.3.2). The 
chondrones are situated along the collagen fibers. They are isolated from other cells, 
blood vessels and nerves. Being metabolically active cells, they produce the extracellular 
matrix, consisting of collagens, glycoproteins, hyaluronic acid and proteoglycans17. Still 
their metabolism varies according to their location in articular cartilage18.  
2.2.1.2 Cytoskeleton and cell migration  
The cytoskeleton of cells is not only important for keeping the shape of the cell upright, 
but also plays an important role regarding load and interaction with its surrounding 
matrix. The main components of the 3D mesh in chondrocytes are f-actin, vimentin and 
tubulin19.   
F-actin is mainly found circular (Figure 2.1.a), like a ring around the cell, while vimentin 
is found between the nucleus and the cell membrane (Figure 2.1.e). Tubulin (Figure 2.1.i) 
is spread through the whole cytosol20. 
 
Figure 2.1. F-actin (a), vimentin (e) and tubulin (i) labeled with fluorescent (source: Trickey et al. 20). 
The actin skeleton changes actively as soon as a cell migrates. In general, cells, which are 
capable of migrating, follow four basic steps. At first the cell needs to polarize, in order 
to know where its front - which will move forward - and its rear is. The main role in 
polarization belongs to the actin filaments, which orientate themselves towards the 
leading margin and are mainly responsible for the movement of the cell. 
In the back of the cell, myosin II causes retraction. Myosin II is depended on actin. It is 
still not known which exact mechanisms cause polarization in cells, but it is very clear 
that it can be caused by multiple ones.  
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The second thing that happens is protrusion. As the actin filaments, at the front of the cell, 
start forming bundles in order to form filopodia, or when they crosslink to form 
lamellipodia, they actually start pushing the cell forward. While forming the protrusion, 
the actin filaments up front are detached from the ones facing the rear part of the cell. As 
soon as it is formed, the protrusion needs to bind to the surrounding matrix. This third 
step, the adhesion, is caused by integrin, which connects the end of the actin fibers to the 
outside matrix. In order to move the whole cell forward, the back part of the cell needs to 
now retract. The last step of cell movement is based on contraction of myosin II and the 
detached actin filaments, which are also called “stress fibers”. The rear part is released 
from the matrix and can now move forward while the protrusion stays in contact with the 
outside surrounding matrix. Now the cycle of cell migration can repeat21. 
 
Figure 2.2. Arrangement of actin fibers forming the actin skeleton of a cell during protrusion. The arrow 
indicates the direction of movement (source: Small et al.22). 
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2.2.2 Tissue 
Articular cartilage in synovial joints needs its special 4-layer structure (zones) in order to 
ensure its unique mechanical and metabolic behavior. 
2.2.2.1 Zones 
The hyaline cartilage has different zones (Figure 2.3) in which the cells and matrix 
components vary. Especially in the upper and the lower zones the amount of cytoplasmic 
cell organelles is increased (for example Golgi apparatus and endoplasmic reticulum)23. 
2.2.2.1.1 The superficial zone 
The superficial zone (tangential) is the thinnest articular cartilage zone that makes out 
about 10% of the cartilage thickness24. It has a slim layer of ellipsoid-flattened 
chondrocytes that are organized parallel to the thin acellular layer, which covers them. 
The acellular layer is a sheet of fine fibrils with very little polysaccharides15. Through this 
layer, the cartilage is clearly separated from the immune system. The superficial zone has 
the highest water content25 but a relatively low content of proteoglycan26. The collagen 
fibers in this layer have a diameter of about 35nm24. 
2.2.2.1.2 The transitional zone 
The transitional zone follows. In this zone, the structure is completely different. The cells 
are shaped much rounder than in the superficial zone and are not as crowded. The zone 
has much more volume than the superficial zone. The cells have more organelles and the 
content of proteoglycan is increased in this zone26 . Collagen fibers in this layer are thicker 
and have a diameter of about 60 nm24. 
2.2.2.1.3 The radial/deep zone 
In the radial zone the chondrocytes are clearly arranged in columns. This zone has the 
least amount of cells. Compared to the other zones, the water content is the lowest and 
the amount of proteoglycans is highest26. The collagen fibers have the largest diameter 
with about 80 nm24 and pass through into the tidemark that separates the non-calcified 
cartilage zones from the calcified layer15.  
2.2.2.1.4 The calcified cartilage zone 
The calcified cartilage zone is the link between subchondral bone and cartilage. 
Depending on the author, the calcified layer is either part of the cartilage or the 
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subchondral bone plate4. The cells in this zone have less volume than the others and are 
often surrounded by calcified cartilage and packed in calcific caverns. These caverns, also 
called lacunae, contain no proteoglycans at all26. In humans, over the age of 60, the 
calcified layer decreases in thickness, while the number of tidemarks is increased27. Large 
collagen fibers cross the tidemark and reach into the calcified cartilage, while there are 
no collagen fibers described crossing the cement line, which separates the calcified zone 
from the subchondral bone plate28,29. Small blood vessels from the subchondral bone reach 
into the calcified layer through channels4. 
2.2.2.1.5 The tidemark 
The tidemark is the separating line between radial zone and calcified cartilage. It is a 
narrow and wavy line and was first described as “tidemark” in 1953 by Fawns and 
Landells30. It is a very active metabolic area, in which chondrocytes and blood vessels are 
found occasionally. There are collagen fibers that do not only cross the tidemark and 
connect with collagen fibers in the calcified cartilage, but lie parallel to it and surround 
the whole tidemark area31. Also, the tidemark has an important biomechanical function. 
As a result of micro fracture for example, it merges into the uncalcified cartilage4. In cases 
of rheumatoid arthritis or osteoarthritis it appears, that the tidemark lines duplicate32. 
 
Superficial Zone
Transitional Zone
Radial Zone
Calcified Zone
Subchondral Bone
Figure 2.3. Zones of articular hyaline cartilage. (Illustration by Serah N. Saitowitz). 
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2.2.3 Matrix 
Although there are cells in cartilage, the extracellular matrix is the main component33. The 
matrix mainly consists of water (about 75 %), proteoglycans and collagens. Collagen 
fibers and proteoglycans make up most of the dry mass33. Hyaline cartilage has 45 % less 
collagen fibers than fibro-and elastic cartilage. It is not supplied with blood vessels or 
nerves15. Chondrocytes often are found in isogenous groups, surrounded by proteoglycans 
(chondrones). In old age, hyaline cartilage seems to fossilize, because the thickness of the 
calcified layer increases. 
2.2.3.1 Collagen 
Collagen forms the framework for all the other matrix components18. The arrangements of 
the fibrils vary, depending on the zone they are in. In the superficial layer, the fibrils are 
orientated parallel to the joint surface, the content is higher18 and the diameter of the fibrils 
is about 31 nm. In the middle/radial zone, collagen is arranged in arcades, which are called 
the “arcades of Benninghoff”, and have a diameter of 40-100 nm. The fibrils of the deep 
zone have the largest diameter and hit the calcified layer vertically by crossing through 
the tidemark.  
Articular cartilage has many different types of collagen. They can be divided in fibril-
forming and non-fibril-forming collagens. With 90-95% occurrence15, type II is definitely 
the most common collagen type in articular cartilage. It is produced by chondrocytes. 
Type IX and XI, as well as V and VI are known as the minor collagens, which contribute 
to the meshwork of type II collagen. Depending on the region around the chondrocyte, 
the collagen thickness and compositions vary. 
2.2.3.2 Chondrones and their regions 
Every chondrocyte lies in a chondrone34, which is matrix and a capsule surrounding the 
cell. This matrix protects the chondrocyte hydrodynamically during physiological load26. 
There are single cell, double cell and multiple cell chondrones (linear cell rows). The 
articular pole of a chondrone faces the articular surface; the opposite side is the basal 
pole, facing the tidemark. In multiple cell chondrones, the basal poles merge. Chondrones 
have different regions, depending on the distance and zone location of the cell. The matrix 
components vary. There is the pericellular region directly surrounding the chondrocyte 
and acting as a protection for the cell or the cell groups15,28,35. Fine collagen fibers form a 
tight mesh around the cell. It preferably contains type VI collagen, which connects 
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directly with the cell surface36,37. It is exclusively found in the capsule of chondrones and 
is not a usual part of the territorial or interterritorial matrices36. Also, Aggrecan (= 
chondroitin/keratan sulfate-containing proteoglycan), link protein, cartilage matrix 
proteins and hyaluronate are found in this region37.  
The following region is called territorial matrix. It contains high concentrations of 
chondroitin sulfate rich proteoglycans. Collagen fibers, which are thicker than in the 
pericellular region, form bundles. The fibrils seem to connect with the pericellular 
matrix38. Adjacent to the territorial matrix one finds the interterritorial matrix, which 
contains an even greater diameter of collagen fibers and a higher amount of proteoglycans 
than the territorial matrix. This matrix zone has the largest distance to the cell and mainly 
contains collagen type II, IX and XI. 
Single cell chondrones, the smallest ones, are mainly found in the middle layer of articular 
cartilage. Double cell chondrones are most often seen in middle and deep zone, they 
consist of two separate chondrocytes, which are associated with one and the same capsule. 
Also, multiple cell chondrones are found, which are basically three or more single cell 
chondrones linked to each other and are found in the deep layer. Type IV collagen 
surrounds all chondrones but is not as present between the adjacent chondrones36. 
 
Figure 2.4. Different shapes of chondrones and chondrocytes in the different zones of articular cartilage (source: 
Youn et al. 39). 
2.3 Subchondral Bone 
The articular cartilage is based on the subchondral bone with the calcified cartilage zone 
as a transitional zone. As already mentioned before, it depends on the author whether the 
calcified layer is part of the cartilage or part of the bone28. Basically, it has two different 
functions: (i) to spread all the pressure and shear forces caused through mechanical load 
equally on to the bone and (ii) to give contour and stability to the articular cartilage18. The 
subchondral bone consists of the subchondral bone plate and the below lying subchondral 
trabecular bone, which is subarticular cancellous bone. It is separated from the articular 
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cartilage through the calcified zone by the cement line. The articular cartilage in turn is 
separated from the bone marrow through both layers of the subchondral bone4.  
The top layer, directly in contact with the cartilage, is the subchondral bone plate. This 
layer borders the subchondral trabecular bone. The subchondral bone plate consists of 
cortical bone, in which the haversian system runs parallel to surface, not like in diaphyseal 
cortical bone, where it runs vertical to the joint surface18. In contrast to articular cartilage 
one finds a lot of blood vessels and nerves in the subchondral bone plate. The number of 
blood vessels and their modeling activity in the calcified zone is different depending on 
load and age40. Through small channels, in which the blood vessels run, the calcified 
cartilage can be reached directly4. Because these channels are not spread out equally, some 
parts of articular cartilage are dependent on diffusion of the synovial fluid as its only 
source of nutrition4. The number of channels varies from joint to joint40. The thickness of 
subchondral bone is different, also depending on joint localization but also species4. 
Collagen fibers from cartilage never cross into the subchondral bone, but abruptly stop at 
the cement line29. 
It is important to know, that mesenchymal stem cells are found in the subchondral bone. 
In case of full-thickness defects, where the subchondral bone is included in the injury, 
these cells can differentiate to chondrocytes, which finally are able to produce matrix and 
repair the lesion, although with lesser quality than the original hyaline cartilage41.  
2.4 Chondrocyte migration  
It is known that chondrocytes are able to migrate in cell cultures within planar or three 
dimensional matrices42. What is not yet proven though, is that chondrocytes also migrate 
in an explant, which keeps its physiological structure, like in the body. Chondrocytes need 
to defeat the pressure and density of the matrix to be able to move. They might be able to 
do this with the help of their actin skeleton42. It was already shown by Lee and Loeser 
(1999) that chondrocytes are able to “grab” collagen fibers that are close by or even lie 
directly on the cells and change their shape in order to move forward43. Type II collagen 
fibers are often bent sharply, while type I collagen fibers are rather gently curved by 
chondrocytes within 48h after adding the fibers to the cells. The chondrocytes manage to 
“grab” the fibers actively and pull them close to the cell body. They seem to get in 
“contact” with the fibers with micro spikes or a cilium44. It was proven that the bending of 
collagen fibers was only possible with the presence of β1-Integrin43. Most of the 
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chondrocytes have a cilium which can change the cell metabolism by being bent. Integrins 
like α1, α2 and β1 are found all over the cilium44. 
2.4.1 Growth plate versus articular cartilage  
In the metaphysis of long bones, during youth, you can find a hyaline cartilage plate, also 
called the epiphyseal plate, physis or growth plate. The growth plate, which consists of 
hyaline cartilage, is the region in which endochondral ossification takes place. There are 
different zones in the growth plate. The zone of reserve contains quiescent chondrocytes 
at the epiphyseal end. The most active chondrocytes are found in the zone of proliferation 
where they undergo constant mitosis accelerated by growth hormone. Further above in 
the zone of maturation, the chondrocytes become hypertrophic, and mitosis is stopped. 
Now the cartilage starts to calcify, which causes apoptosis of the cells.  The calcified 
cartilage is replaced by osteoblasts and osteocytes in the zone of ossification. After 
puberty, the growth stagnates. An increase of estrogen causes the apoptosis of the 
chondrocytes and ends the bone growth. The growth plates are fully resorbed and replaced 
by bone45. In adolescents, all that remains is an epiphyseal line. 
Because the growth plate consists of hyaline cartilage and has a calcified zone, similar to 
hyaline cartilage in joints, it is assumed that the cells behave the same way. This is the 
reason for the assumption that cells below the tidemark, in the calcified cartilage layer of 
articular cartilage behave like chondrocytes in the growth plate and are slowly 
progressing to “terminal differentiation”, hypertrophy and death. Hypertrophic cells 
increase their size and change their shape. Additionally, the cells in the calcified cartilage 
produce collagen X and stage specific matrix46. Although the role of collagen X is not 
clear yet, it is known that it is produced during calcification of cartilage and chondrocyte 
hypertrophy47 in the growth plate. The main difference between growth plate and articular 
cartilage is, that the cartilage becomes bone during endochondral ossification and 
calcifies. The growth plate undergoes continuous vascular invasion and endochondral 
ossification until skeletal maturity.  
Separating the calcified from the non-calcified cartilage the tidemark is an undulating 
line, which is only found in hyaline cartilage. In adults or non-growing joints the tidemark 
is most prominent and can duplicate as a result of inflammation or increasing age. The 
tidemark is in joints from the beginning on, and can be found in the growth plate from 
time to time.  
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2.4.1.1 Difficulties  
To copy the in vivo situation of chondrocytes in articular cartilage and in order to track 
the cells in their natural surroundings, osteochondral explants have to be not only 
harvested in a way that cartilage and subchondral bone do not separate, but also without 
damaging the cells.  
Currently it is impossible to recreate an artificial osteochondral interface that is three-
dimensional. The culture of cells in two-dimensional models is too simple and ignores 
many known parameters, which cells need for proliferation for example and for 
homeostasis of the tissue. Especially mechanical aspects but also the interaction between 
cells as well as between cells and matrix are not given in two-dimensional models. Three-
dimensional models would be the solution. Until now there is no common way to create 
a 3D osteochondral model and still be able to visualize activity on a cellular level. It is 
difficult to recreate a tissue with different cell types in different zones, especially without 
causing that these cell types dedifferentiate. Besides that the matrix of the subchondral 
bone is completely different from the chondrogenic matrix48.  
Cartilage tissue is harvested and cartilage explants are maintained in vitro in order to keep 
the chondrocytes within their natural three-dimensional matrix, which we are presently 
unable to replicate. Harvesting a cartilage explant with adjacent subchondral bone is one 
step further in ensuring that the environment of the osteochondral interface is maintained 
as close to that found in vivo as possible.  
To visualize live cells in vivo or in vitro within a tissue or an organ, as it is the case in 
osteochondral explants, a dye is needed, which is minimal invasive and does not affect 
the functionality of the cells. The use of viral vectors expressing GFP as a transgene is a 
good way to stain live cells with green fluorescence. The fluorescence proves the cells 
viability as they need to produce the transgene, which allows the tracking of cells 
containing the produced GFP protein. Despite the embedded proof of viability, viral 
vectors are very invasive, especially regarding the metabolic activity each cell goes 
through in order to constitutively express GFP. Other stains specific to the cell membrane 
or intracellular proteins such as actin may be less invasive. Their presence however does 
not inherently prove cell viability and an additional viability test must be performed. 
To date, there is unfortunately no chondrocyte-specific stain available, which labels live 
cells and persists with cell proliferation. For future in vivo cell tracking studies, new 
solutions must be found to both target and reliably tag a cell within its native tissue 
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environment. Such a tracking molecule could then possibly be delivered intraarticularly  
to allow specific cell labeling. 
Besides the issues regarding the tissue itself, tracking chondrocytes over a certain amount 
of time in 3D using Confocal Laser Scanning Microscope (CLSM) need a steady setup 
of the sample with no movement of the explant itself, in order to track single cells within 
the tissue. Without affecting the explant and causing irritation of the cells, it is very 
challenging to fix the osteochondral slice to the bottom of a well plate. CLSM allows the 
imaging of fluorescence-tagged cells in a 3D tissue, with notable tradeoffs in resolution. 
One is then able to live track a cell movement within a 3D tissue over hours or days using 
time-lapse imaging. While fluorescent signal bleaching may be a concern in some cases, 
the laser influence on cell and tissue function over a longer time period within a time-
lapse however has not been reviewed yet.  
2.5 Articular cartilage degeneration 
2.5.1 The process and landmarks of articular cartilage degeneration  
It is a fact that articular cartilage starts to degenerate after injury has occurred. The loss 
of cartilage structure and function causes the clinical syndrome of osteoarthritis49. In turn, 
osteoarthritis is defined as a degenerative disease of the joint, hypertrophic or 
degenerative arthritis, which consists of a loss of articular cartilage with an attempt of 
repair as well as remodeling and sclerosis of the underlying subchondral bone50. 
Osteoarthritis is of great importance as it is a prevalent musculoskeletal disease in the 
world and one of the most common reasons for causing disabilities51. The first and main 
clinical changes in a degenerating joint are loss of cartilage, remodeling of subchondral 
bone and formation of osteophytes. Microscopically fibrillation and fraying of the top 
two layers of cartilage is observed. These irregularities of the cartilage surface can 
become clefts and even fissures, which can reach down to the subchondral bone. In 
sclerosis  the subchondral bone stiffens up, which may cause delamination of the cartilage 
zones.  In severe cases the cartilage may get over compressed due to the load on the joint 
and finally complete denudation of the subchondral bone may be caused52. In that case, 
blood vessels can break through the tidemark and cause it to multiply or thicken. The 
cartilage itself decreases its thickness through enzymatic degradation53, although the 
matrix initially swells due to increasing water content.  
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Further during cartilage degeneration, one can find multiple chondrones lying together in 
one large lacuna54. These groups of chondrones are defined as clusters. Clusters are typical 
indicators for osteoarthritis. They are primarily found at the edges of the clefts or fissures 
in order to shorten the pathway of diffusion. Cluster formation is a result of chondrocyte 
proliferation54, in turn chondrocytes in clusters still have the potential to proliferate55.  
Depending on the type of defect, the repair mechanisms are different. 
2.5.1.1 Chondral full-thickness defects 
In chondral full-thickness defects (Figure 2.5), the cartilage is disrupted. Because the full-
thickness of cartilage is damaged, the subchondral bone is exposed but still intact. Canals 
through which tiny blood vessels reach into the calcified cartilage can be exposed.  
In most cases, no fibrin clot can fill the defect, which causes a lack of inflammation. Still 
matrix macromolecules are synthesized and the cells proliferate. However, the newly 
produced tissue is not capable of filling the defect fully56.  
 
 
In case enough blood vessels from the calcified cartilage layer are exposed, the cleft can 
be filled with a fibrin clot tissue, which is produced by mesenchymal cells of the 
subchondral bone. In this case, the defect is replaced with either fibrocartilage or hyaline-
like cartilage tissue.  
Figure 2.5. Chondral full-thickness defect (Illustration by Serah N. Saitowitz). 
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2.5.1.2 Chondral partial-thickness defect 
 
 
Initially the subchondral bone as well as the cartilage below the tidemark is not affected 
through the injury (Figure 2.6). In this case the disruption of the surface is often not even 
visible. In this case, blood vessels from the subchondral bone cannot reach the defect. No 
typical way of healing can occur due to the fact that no fibrin etc. reaches the wound. In 
case the matrix basis is not destroyed and enough viable cells are available, cell 
proliferation as well as matrix synthesis takes place and healing may be possible 
depending on the size of the defect. If there is a lack of viable cells or the matrix basis 
structure is destroyed, the matrix will change its properties and no healing will take place56. 
2.5.1.3 Osteochondral defect 
 
Figure 2.7. Osteochondral defect (Illustration by Serah N. Saitowitz). 
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Figure 2.6. Chondral partial-thickness defect (Illustration by Serah N. Saitowitz). 
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Here the subchondral bone is part of the defect and the bone marrow cavity is exposed 
(Figure 2.7). In this case, blood vessels are also affected and blood as well as 
inflammatory factors can reach the defect. In this case the defect can be filled with a fibrin 
clot containing pluripotent undifferentiated MSCs, which then can differentiate into 
chondrocytes and osteoblasts through present growth factors4,56. Inflammation takes place, 
the new cells invade the region of defect and the healing pathway can proceed.  
Very often though, lesions of this size do not heal, but tend to progress due to load and 
movement56. 
2.5.2 Failure of articular cartilage healing  
The main two reasons for the failure of healing in articular cartilage are, that first of all, 
not every disruption of the tissue leads to denudation down to the subchondral bone and 
subsequent bleeding and thus to a fibrin clot following inflammation and production of 
new cells and tissue; second, the process of cartilage healing takes time and is, due to its 
very strained position in the body, not always able to heal in time, before the load or 
movement of the joint causes the defect to deteriorate and increase56. 
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3 Material and methods 
3.1 Study design 
The methodology used in this thesis expanded on the work described in the thesis of 
Dr.med.vet. Sophie Schöberl1. The main aim was to demonstrate the migration of cells 
from subchondral bone into the articular cartilage.  
3.1.1 Method establishment in vitro 
The method was established using osteochondral explants, which were taken from the 
humeral head of the shoulder joint of sheep. These sheep were slaughtered for other, 
unrelated experiments, and the harvest of tissues for this thesis did not have an impact on 
the study design of the other experiments. Similarly, the treatments applied to the sheep, 
from which the samples were taken, did not impact the tissues harvested for the 
experiments described herein. The details of the other experiments are not described in 
this thesis for confidentiality reasons. Once the fresh osteochondral explants were 
harvested, they were prepared as 200-300µm thick slices that could be microscopically 
imaged in the CLSM. Various cell tagging methods were tested as well as special agarose 
filled wells, which were designed to culture the tissue explants and track the cells 
movement within using time-lapse imaging with the CLSM. Explants were also 
stimulated with pro-inflammatory substances to promote their migration and 
proliferation. 
3.1.2 In vivo experiment 
Once the method was established in vitro, an in vivo experiment was conducted in a sheep 
model. Briefly, a standardized metaphyseal defect in the proximal tibia was created in 
one stifle joint of 4 sheep, just 4mm below the cartilage surface. Two of the sheep 
received post-operative transdermal application (TDA) of an anti-inflammatory drug, 
while two did not receive any treatment after surgery. The osteochondral explants 
harvested from these four sheep after sacrifice were used to investigate cell migration 
through the calcified cartilage zone, and the impact of inflammation on osteochondral cell 
behavior. 
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3.2 Experimental animals 
All samples for the in vitro establishment of the method were taken from healthy female 
sheep, after sacrifice. The animals did not show any obvious changes in cartilage or bone 
while harvesting the explants, therefore the tissue was considered healthy at the time of 
harvest. The animals were all between 12 and 36 months old (average of 24 months).  
For the in vivo part of this study with the metaphyseal defect 4 healthy female sheep at 
the age of 24 months (born 03/2014) were operated and samples were taken from the 
cartilage layer above the created metaphyseal defect in the tibia. The tissue harvested in 
this case was expected to have undergone some level of degeneration, which may have 
been partially rescued by the anti-inflammatory treatment. This animal experiment, which 
required an in vivo component, was conducted according to the Swiss laws of animal 
protection and welfare (Tierschutzgesetz (TSchG) 455) and authorized by the cantonal 
ethical committee under the license no. ZH165/15. 
3.3 In vivo animal experiment 
3.3.1 Medication/Substances/Materials 
• Attane®, isoflurane (Piramal Healthcare Limited, Tamil Nadu, India) 
• Chlorhexidin, (Mölnlycke Health Care AG Brandstrasse 24, 8952 Schlieren, 
Switzerland) 
• Diclo Hyal TDA®, (Arivine Pharma AG, 8008 Zürich, Switzerland) 
• HibiScrub®, (Mölnlycke Health Care AG Brandstrasse 24, 8952 Schlieren, 
Switzerland) 
• Ketonarkon 100®, ketamine, (Streuli Pharma AG, 8730 Uznach, Switzerland) 
• Midazolam Sintetica®, midazolam, (Sintetica S.A., 6850 Mendrisio, Switzerland) 
• Penicillin Natrium Streuli®, benzylpenicillinum, (Streuli Pharma AG, 8730 
Uznach, Switzerland) 
• Piezosurgery®, (Mectron s.p.a., medical technology, 16042 Carasco, Italy) 
• Propofol 1% MCT Fresenius®, propofol, (Fresenius Kabi AG, 4436 Oberdorf, 
Switzerland) 
• Rimadyl®, carprofen, (Zoetis Schweiz GmbH, 8052 Zurich, Switzerland) 
• Temgesic®, buprenorphin, (Indivior Schweiz AG, 6340 Baar, Switzerland) 
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• Tetanus-Serum®, equine tetanus antitoxin, (MSD Animal Health GmbH, 6000 
Lucerne, Switzerland) 
• Vetagent®, gentamicin, (MSD Animal Health GmbH, 6000 Lucerne, Switzerland) 
• Vitamin A® Augensalbe, retinol, (Bausch & Lomb Swiss AG, 6301 Zug, 
Switzerland) 
• Xylazin Streuli®, xylazine hydrochloride, (Streuli Pharma AG, 8730 Uznach, 
Switzerland) 
3.3.2 Pre- and Perioperative Treatment 
After the animals arrived at the Musculoskeletal Research Unit (MSRU) in Zurich, they 
were examined and weighed by veterinarians. Blood samples were taken 2 days after 
arrival, to check the general condition of the sheep and to make sure the animals were in  
healthy for anesthesia purposes. The only parameter, which was slightly increased, was 
creatinine kinase (CK). However this is normal shortly after transportation.   
 Control Diclofenac 
Animal ID 54.01 54.04 54.03 54.06 
Weight 54,8 kg 69,0 kg 56,9 kg 62,7 kg 
Table 3.1. Bodyweight of sheep. 
All animals were fasted for 24 hours before surgery. During this time, they only had 
access to water ad libitum. Before surgery, the animals were examined thoroughly by a 
veterinarian and then received premedication such as xylazine (xylazine hydrochloride 
0.1mg/Kg BW) and buprenorphine (buprenorphine HCl 0.01 mg/Kg BW) 
intramuscularly. After 20-30 minutes, the skin in the region of the jugular vein was 
clipped and cleansed in a sterile manner. Then a catheter (14 G) was placed into the 
jugular vein and fixated with suture material. Further medication was given for pain 
control and antibiosis (carprofen 4 mg/Kg BW, gentamicin 4 mg/Kg BW, penicillin 
30000 IE/Kg BW (= 0,06 mL/Kg BW) intravenously and tetanus serum (3000 IU/ Dose= 
3 mL/animal) was given subcutaneously.  
For induction of anesthesia, the animal was brought to the operation room. Here the 
animal received ketamine (3-5 mg/Kg BW), midazolam (0,1 mg/Kg BW) and propofol 
(0,4-0,6 mg/Kg BW or as needed) through the jugular catheter. After waiting a few 
minutes the animal was placed in sternal recumbency. An assistant stretched the neck and 
opened the mouth, so that the anesthesiologist could see the larynx with help of a 
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laryngoscope and spray it with Lidocaine. After about 90 seconds the tube was placed in 
the trachea and was cuffed and then tied to the jaw. The animal was placed on the surgery 
table and the tube connected to the anesthesia machine. The anesthesia was maintained 
with inhalation of 1-2 Vol% of isoflurane in oxygen and a constant-rate infusion with 
propofol was administered.  
On the surgery table the sheep was placed in lateral recumbency. The upper hind limb 
was padded with a bandage just above the fetlock joint and then tied in flexion to the left 
table side in cranio-dorsal direction (Figure 3.1).  
 
Figure 3.1. Positioning of sheep during the surgery (Illustration by Serah N. Saitowitz). 
In this position, it was easy to approach the medial side of the hind limb stabilized firmly 
on the table on an inflatable mat. The limbs were clipped and cleansed in a sterile manner 
(chlorhexidine and HibiScrub, Mölnlycke Health Care AG, Switzerland). 
3.3.3 Surgery procedure 
An incision of about 8 cm was performed at the medial aspect of the tibia shaft extending 
from the middle of the stifle joint at the height of the patella down to the metaphysis of 
the proximal tibia. Bleeding was controlled with electro cautery.  The soft tissue and 
fascia were incised. A wound retractor was used to expose the site of the planned defect. 
The space between the medial meniscus and the proximal rim of the tibia, as well as the 
lateral collateral ligament of the stifle joint were identified and marked with hypodermic 
needles (Figure 3.2). The needles were placed into the joint space carefully in order to not 
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harm the cartilage. The two needles (20 G x 1 1/2") were placed to determine the slope 
of the tibia plateau.   
 
Figure 3.2. Surgery field with needles marking the rim of the tibia plateau. The arrow indicates the collateral 
ligament (CL). 
The soft tissue was dissected down to the bone cranially to the collateral ligament. The 
periosteal elevator was used to cleanse the bone of all adhering tissue.   
A prepared metal template of 1.0 cm height, and 1.5 cm width was adjusted to mark the 
planned defect region directly cranially of the collateral ligament and 4 mm below the 
proximal rim of the tibia (Figure 3.3). The distance from the rim of the proximal tibia was 
measured from the previously placed hypodermic needles, thus, placing the templates 
parallel to the slope of the tibia plateau. The outline of the defect was marked using 
electrocautery. Then the template was removed and the rectangular defect created parallel 
to the hypodermic needles using a piezoelectric surgery scalpel.  
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Figure 3.3. Placement of the template  on the medial side of the tibia, in order to create the metaphyseal defect. 
The arrow indicates the CL. 
Once the cortical slot was made, the bone block was carefully lifted. For this, a small 
osteotome was slid along the four walls of the cortex by carefully tapping on the tip of 
the osteotome with a hammer. Thereafter, the cancellous bone block was carefully 
removed and the desired depth of the defect was further deepened with the piezoelectric 
scalpel and curette (depth 1.8 cm). The depth of the defect was measured in all four 
corners with a depth gauge to assure adequate length.  
The created tibia slot (Figure 3.4 (A)) was filled with the same bone that was taken out 
as a block (autograft) (Figure 3.4 (B) ). Before filling it in, the extracted bone was crushed 
into small pieces with a rongeur. Then the wound was closed with degradable suture 
material (Vicryl, 2-0) and the skin with surgical staples. 
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Figure 3.4. Metaphyseal defect in the tibia without (A) and with the created autograft (B). 
3.3.4 Postsurgical treatment 
After recovery, the animals were taken back to the stable, where they received food (hay 
twice per day) and water (ad libitum). No further stabilization of the limb was needed. 
According to our monitoring procedure, the sheep received analgesics (buprenorphine 
0,01 mg/Kg BW) every four hours for a total of four times (including the one application 
before surgery) on the day of the surgery. Twelve hours after the first application of 
penicillin, the animals received a second dose intravenously (30000 IE/Kg BW). The 
operated animals were treated with penicillin, gentamicin and carprofen for a total of five 
days post-surgery including the day of surgery. 
The sheep of the “Diclofenac Group” got 1 mL of Diclo Hyal TDA® transcutaneous  
immediately after surgery and then daily for 14 days. The TDA-system allows 
transcutaneous application of substances, which are bound to liposomes and oxygen as 
carrier materials. It is “blown” onto the area of the joint space with this special Meddrop 
device. The TDA system consists of an air compressor and a hand-held device for the 
application. The compressor extracts oxygen from the atmosphere and this high 
concentrated oxygen serves as a carrier substance for the anti-inflammatory Diclo Hyal 
TDA®. The oxygen stimulates and transports the carrier substance under pressure, while 
A B
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also mixing with it. The system causes a so-called Venturi-effect (in response to a 
constricted flow area the fluid pressure decreases), so the micro emulsion is atomized. 
The drops, which hit the skin, are in the nanometer range dimension regulated by the 
needle at the end of the device. The substances are based on oil-in-water or water-in-oil 
microemulsion. The active ingredient is transformed into a watery phase, so it can bind 
with adjuvants and the surface tension of the drop is broken. Now the active substance 
can be dissolved without binding particles57.  
The sheep’s limb was always clipped in the region of treatment and cleansed with ethanol 
before application. The substance was applied onto the skin in a 90° angle to the surface 
and a distance of about 1cm (Figure 3.5). 
Veterinarians observed all sheep at least twice a day and their condition was noted in the 
impatient record of each animal.  
  
Figure 3.5. Treatment of the metaphyseal defect with the TDA system. 
 
 Diclofenac Group Control Group 
Life span 14 days 14 days 
Treatment post-surgery 1mL Diclofenac daily - 
Amount of animals  2 2 
Table 3.2. Groups for experimental animal model. 
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3.3.5 Sacrifice 
Two weeks post-surgery, the animals were taken to the slaughterhouse of the Vetsuisse-
Faculty in Zurich. They were brought into the slaughter room separately and stunned 
manually with a bolt. In order to stun a sheep, the bolt has to be placed in the middle of 
the head, behind the horn-basis of the animal and has to be aligned with the mouth. 
Immediately after the stunning (maximum stun to stick/kill interval is 60 seconds 
according to the Swiss law of animal protection VTSchS 455.110.2 attachment 2), the 
throat was cut and the sheep were hung at their hind limbs in order to bleed out as rapidly 
as possible. After bleeding, the limbs were detached of the carcass and were now ready 
for the sample harvest. 
Figure 3.6. Position of the bolt for the stunning procedure of hornless sheep (source: Swiss animal protection 
law, VTSchS 455.110.2 attachment 2c). 
3.4 Sample harvesting and processing 
3.4.1 Sample extraction  
Sample harvesting was performed under aseptic conditions. The skinned forelimb was 
separated from the corpus immediately after slaughtering, leaving the shoulder joint 
intact. The sample extraction itself took place in the veterinary anatomy institute of the 
Vetsuisse Faculty in Zurich, Switzerland.  
For the in vitro establishment of the method, the samples were taken from healthy 
animals, sacrificed for other studies. The diaphysis of the humerus was wedged into a 
bench vice with the scapula facing up. The shoulder joint capsule was opened under sterile 
conditions and the head of the humerus was immediately irrigated constantly with sterile 
sodium chloride, so that the cartilage would not dry out during extraction. With the 
OATS® System (by Arthrex) and a hammer, explants (8mm diameter) were taken in a 90° 
Material and methods 
29 
angle and immediately put into cold HBSS + 1% penicillin/streptomycin + 55mM sodium 
citrate in centrifuge tubes that were placed on ice.  
 
Figure 3.7. Illustration of sample harvesting with OATS from a shoulder joint (source: Schoeberl et al.1). 
The exact same procedure was done with the operated sheep with the metaphyseal 
defects. The only difference here was that the explants were taken from the tibia plateau 
of the operated hind limb (Figure 3.8). The knee joint was approached under sterile 
conditions and the osteochondral plug taken from the tibia plateau in the region above the 
created defect. Explants were taken within the defect as well as some on the border of the 
defect.  
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Figure 3.8. Illustration of metaphyseal defect region by M.Haab(left). Region of interest for harvesting plugs 
(right). 
 
Due to the tibia slot, which was filled with autografts, it was difficult to take the 
osteochondral explants because the underlying bone would break away (Figure 3.9, 
Figure 3.10). Still it was possible to take the samples including the remaining subchondral 
bone.  
 
 
Figure 3.9. Tibia after harvest of osteochondral plugs (left image). Region of healed defect indicated by the arrow 
(right image). 
10 mm 
18 mm 
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Figure 3.10. Tibia plateau after harvesting plugs above the created metaphyseal defect. 
 
3.4.2 Preparation 
After harvesting the explants, they were washed in HBSS + 1% penicillin/streptomycin 
twice. Then the cancellous bone was taken off bit by bit with a hand rongeur until only 
the subchondral bone and the calcified cartilage zone were left (Figure 3.11). At the end, 
all plugs had a diameter of 8mm and were about 2 mm thick after removing the cancellous 
bone.  
 
Figure 3.11. Breaking down the lugs with a hand rongeur (source: Schoeberl et al.1). 
Material and methods 
32 
After washing the plugs again in HBSS + 1% penicillin/streptomycin and twice in pure 
sodium chloride they were put on a shaker for 30 min (250 rd/min) in HBSS+ 5% 
penicillin/streptomycin. They were then placed on the shaker again for 15 min in a tube 
with HBSS + 1% penicillin/streptomycin + 55mM sodium citrate. Thereafter, the plugs 
were cut into thin slices by hand with a sterile scalpel in a petri dish with PBS (Figure 
3.12). The slices were about 2mm x 0,3mm x 1mm. The thickness of 300µm varied 
slightly, because they were cut by hand. Also, the width was not always the same because 
the plugs were round originally. After cutting the slices they were put back into complete 
cell culture medium (see below).  
3.5 Explant Culture In Vitro 
3.5.1 List of Materials 
3.5.1.1 Chemicals and Reagents 
• Amphotericin B (Catalogue no. A4888, Sigma-Aldrich Chemie GmbH, Buchs, 
Switzerland) 
• Bovines Serum Albumin (Catalogue no. A2058, Sigma-Aldrich Chemie GmbH, 
Buchs, Switzerland) 
• Dulbecco`s Modified Eagle Medium/F12 D8437 (Catalogue no. D8437, Sigma-
Aldrich Chemie GmbH, Buchs, Switzerland) 
• Ethanolum Ketonatum 70% (Catalogue no. 02-6000-08, Hänseler AG, Herisau, 
Switzerland) 
Figure 3.12 . Cutting slices of the harvested plugs (source: Schoeberl et al. 1). 
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• Fetal Bovine Serum (Catalogue no. 10437010, Life Technologies Europe B.V., 
Zug, Switzerland) 
• Formalin 4% buffered (Catalogue no. 84-1951-05, Biosystems AG / J.T. Baker) 
• Hank’s Balanced Saline Solution (Catalogue no. 14175-053, Life Technologies 
Europe B.V., Zug, Switzerland) 
• Lipopolysaccharides from Escherichia coli 0111:B4 (Catalogue no. L4391, γ-
irradiated, BioXtra, suitable for cell culture) (Sigma-Aldrich Chemie GmbH, 
Buchs, Switzerland)  
• Penicillin-streptomycin (Catalogue no. P4333, Sigma-Aldrich Chemie GmbH, 
Buchs, Switzerland) 
• Phosphate buffered saline (Catalogue no. 10010015, Life Technologies Europe 
B.V., Zug, Switzerland) 
• Sodium Chloride 0.9% (Catalogue no. AUST R 29745, Fresenius, Bad Homburg 
v.d.H., Germany) 
• Sodium citrate tribasic dihydrate (Catalogue no. 71404-250G, Sigma-Aldrich 
Chemie GmbH, Buchs, Switzerland) 
• (+)-Sodium L-Ascorbate (Catalogue no. 11140, Sigma-Aldrich Chemie GmbH, 
Buchs, Switzerland) 
3.5.1.2 Instruments 
• Benchtop pH-Meter (Mettler-Toledo Ltd., Beaumont Leys, Leicester, UK) 
• Incubator Sanyo MCO-18AC (UV) (Sanyo Electric Co.; Ltd. Osaka, Japan) 
• OATS®, Osteochondral Autograft/Allograft Transfer System (Arthrex, Naples, 
FL, USA) 
3.5.1.3 Other Consumables 
• Centrifuge Tubes 15mL (Catalogue no. 91017, TPP Techno Plastic Products AG, 
Trasadingen, Switzerland) 
• Centrifuge Tubes 50mL (Catalogue no. 91054, TPP Techno Plastic Products AG, 
Trasadingen, Switzerland) 
• Eppendorf Safe-Lock Tubes, 1.5 mL (Catalogue no. 0030120086, Eppendorf, 
Vaudaux-Eppendorf, Switzerland) 
• IBIDI µ-Dishes, 35mm (Catalogue no. 80136-IBI, Vitaris AG, Baar, Switzerland) 
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• Serological pipettes (2; 10; 25; 50ml), (Catalogue no. 2mL, 86.1252.025, 10mL 
86.1254.001, 25mL 86.1685.020, 50mL 86.1689.001 Sarstedt, Nümbrecht, 
Germany) 
• Syringe Filter, 0.22µm, (Catalogue no. 99722, TPP Techno Plastic Products AG, 
Trasadingen, Switzerland)  
• Tissue Culture Test Plates (6, 24, 96) (Catalogue no. 6-wells 92006, 24-wells 
92024, 96-wells 92096, TPP Techno Plastic Products AG, Trasadingen, 
Switzerland) 
• Vacuum Filtration "rapid"-Filtermax (Catalogue no. 99500, TPP Techno Plastic 
Products AG, Trasadingen, Switzerland) 
3.5.2 Explant Culture in Growth Media 
Osteochondral explants were taken from the humeral head of sheep or the tibia plateau 
with the Osteochondral Autograft Transfer System (OATS® by Arthrex) immediately 
after approaching the joint. These explants, or plugs, were placed into growth media, 
composed of Dulbecco`s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12 
by GIBCO®) with fetal bovine serum (FBS by GIBCO®), penicillin and streptomycin, 
amphotericin B and vitamin C (shown in Table 3.3). The explants were kept in a 
humidified atmosphere at 37°C with 5% CO2 and the media was changed 2 to 3 times per 
week. The same culture procedure was used for osteochondral plugs and osteochondral 
slices made from plugs. 
Ingredients for explant growth media Amount in % 
DMEM/F12 89 
FBS 10 
Penicillin/streptomycin, 100x Stock:  
 (100 U/ml penicillin, 10μg/ml streptomycin) 1 
Vitamin C, 1000x Stock (25μg/ml) 0.1 
Amphotericin b, 1000x Stock (5μg/ml) 0.1 
Table 3.3. Explant culture media ingredients. 
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3.5.3 Stimulation of cells with LPS 
In this set of experiments, no treatment of the cartilage or tissue was performed in vivo. 
Only healthy explants were taken and all treatments and stimulations were done in vitro. 
Plugs were harvested from the healthy humeral head of the shoulder joint, after the 
sacrifice of these sheep for an unrelated study. The plugs were then cultured in growth 
media, then placed in agarose and stimulated with LPS before imaging, as shown in 
Figure 3.13. 
Gram-negative bacteria, like Escherichia coli, are surrounded by a kind of casing, which 
gives the bacteria its shape. On the outer side of this, which is pointed to the bacteria’s 
environment, the casing is covered with proteins58. Of these proteins, Lipopolysaccharide 
(LPS) covers almost three quarters of an E.coli bacteria. Bacterial mutants, which are 
unable to form LPS cannot survive59. Toxicity of gram-negative infections and 
inflammatory processes are mostly influenced and caused by LPS. Relating to other 
research, LPS does increase proliferation60,61. In order to give the cells a “kick-start” or to 
create a similar inflammatory situation as in osteoarthritis,  LPS was added to the cell 
culture medium for certain time periods before imaging. 1 mg LPS from Escherichia coli 
0111:B4 (γ-irradiated, BioXtra, suitable for cell culture) (Sigma-Aldrich Chemie GmbH, 
Buchs, Switzerland) was dissolved in 1 mL HBSS. In order to find the right dosage to 
cause stimulation but no damage to the cartilage and bone cells of the explant we tested 
LPS at a concentration of 1µg/mL and 2 µg/mL in growth media or growth media alone 
(control). For the dosage test, the explants were kept in contact with the LPS-containing 
media for 24h, 48h or 72h. 
The LPS-stimulation in vitro experiment was set up according to the basic scheme below 
(Figure 3.13). Briefly, explants were kept in growth media for a short (2-4 days), mid (10-
13 days) or long (18-21 days) period (Figure 3.14). Afterwards, LPS was added to the 
growth media for a total of 4 or 7 days. During the last 3 days of culture, samples were 
imaged using time-lapse microscopy, as described below in chapter 3.7. 
 
 
Figure 3.13. Overall setup of LPS stimulation experiments. 
 
Culture Agarose +/– LPS Imaging
Harvest
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Figure 3.14. Detailed setup of LPS stimulation experiments, including culture times in growth media as well as 
stimulation times in LPS and imaging time frames. 
Table 3.4. Table summarizing the experimental groups for LPS-stimulation experiments. 
3.6 Visualization of cells 
In order to image cells in the CLSM, a few different methods were established. 
The goal was to visualize cells with stains that would not influence the viability of cells 
in the osteochondral plugs. Staining multiplying and non-multiplying cells (which are in 
the resting phase G0, for example) was as important as keeping the signal for weeks. 
3.6.1 List of Materials 
3.6.1.1 Chemicals and Reagents 
• Adeno Associated Virus-Typ2 NEO (Virology Institute, Francesca Franzoso, 
University Vetsuisse Zürich, Switzerland) 
• CellTracker™ Blue CMAC Dye (Catalogue no. C2110, Life Technologies 
Europe B.V., Zug, Switzerland) 
• CellTracker™ Green CMFDA Dye (Catalogue no. C2925, Life Technologies 
Europe B.V., Zug, Switzerland) 
Experiments
2-4	days +/– LPS	4	days
10-13	days +/– LPS	4	days
18-21	days +/– LPS	4	days
2-4	days +/– LPS	7	days
10-13	days +/– LPS	7	days
18-21	days +/– LPS	7	days
Culture Agarose	+/– LPS
Harvest
Imaging
4d
7d
Days in culture 
after harvesting 
Short term:  
LPS total 4 days 
(added 1 day before 
imaging) 
Midterm: 
LPS total 7 days 
(added 4 days 
before imaging) 
Short term: 
No LPS 
Midterm: 
No LPS 
2-4 days Group 3 Group 4 Group A Group D 
10-13 days Group 5 Group 1 Group B Group E 
18-21 days Group 2 Group 6 Group C Group F 
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• Lentivirus Vector FUGW (Virology Institute Bruna Pareira/Anita Meyer, 
University Vetsuisse Zürich, Switzerland) 
• Live/Dead Cell Viability Assay (Catalogue no. L3224, Life Technologies Europe 
B.V., Zug, Switzerland) 
• Methanol (Catalogue no.	BDH1135-1LP, VWR International GmbH, Dietikon, 
Switzerland) 
• Phosphate buffered saline (Catalogue no. 10010015, Life Technologies Europe 
B.V., Zug, Switzerland) 
3.6.1.2 Instruments 
• Incubator Sanyo MCO-18AC (UV) (Sanyo Electric Co.; Ltd. Osaka, Japan) 
3.6.1.3 Other Consumables 
• Eppendorf Safe-Lock Tubes, 1.5 mL (Catalogue no. 0030120086, Eppendorf, 
Vaudaux-Eppendorf, Switzerland) 
• IBIDI µ-Dishes, 35mm (Catalogue no. 80136-IBI, Vitaris AG, Baar, Switzerland) 
• Serological pipettes (2; 10; 25; 50ml), (Catalogue no. 2mL, 86.1252.025, 10mL 
86.1254.001, 25mL 86.1685.020, 50mL 86.1689.001 Sarstedt, Nümbrecht, 
Germany) 
3.6.2 Cell labeling with viral vectors 
Viruses have been used as therapeutics for more than 200 years, starting off with the aim 
to produce vaccines in order to prevent the smallpox disease. Besides the great interest in 
using viruses for vaccines, they are also often involved in gene therapy processes62. Part 
from this, viral vectors can also be used for visualization of cells. 
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3.6.2.1 GFP-AAV-vector 
Adeno-associated viruses (AAV) were first discovered in 1960. They belong to the family 
of the parvoviridae and are replication-deficient. The genus is the so-called dependovirus, 
because they are dependent on a helper-virus or cellular stress to replicate and express 
genes. If no helper-virus is around, AAV can still infect a cell, but it will cause a latent 
infection, which can be activated by stress or super infection.  
An AAV has an icosahedral shape. Its single-stranded DNA has approximately 4.7 kb. 
The genome contains two clusters of genes rep and cap which are flanked by so-called 
ITRs (inverted terminal repeats; Figure 3.15). Rep encodes for proteins, which are needed 
for replication, and cap encodes for proteins, which make up the capsid. The basis to 
produce an AAV vector is, that rep and cap can be deleted from the genome. The missing 
genes can be replaced by transgenes with control elements regarding the transcriptional 
process. When the AAV infects human cells, its genome remains episomal in the cell 
nucleus or is integrated into the host cell genome, preferentially at the so-called AAVS1 
locus on chromosome 19. For this site-specific integration, the rep-proteins (replication) 
are required. The rtAAVGFP- Neo vector, which was used in this case, is totally 
apathogenic, as the rep part is removed from the vector, so it is non-integrating. The 
vector rAAVGFP Neo, has a small non-enveloped virus capsid with a diameter of 20-
25nm63.  
 
 
Figure 3.15. rAAVGFP-Neo genome. 
 
ITR ITR rep cap ITR ITR 
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Figure 3.16. AAV-viral vector rAAVGFP-Neo (source: Dr.med.vet. Francesca Franzoso, dipl. ECVP, Virology 
institute Vetsuisse Faculty Zurich, Winterthurerstrasse 266a, 8057 Zurich, Switzerland). 
3.6.2.2 Infection with AAV-Vector 
The sliced explant samples in 100µL media (DMEM/F12) were placed into a 96-cell 
culture well plate. 20 µL of virus suspension were added to each sample. After infection 
with viral vectors the samples were incubated at 4 °C for 30 minutes in a fridge and then 
at 37°C, 5% CO2 in a humidified standard cell culture incubator for 23 hours (MOI 5000). 
24 hours post infection the samples were transferred into a six-well plate with each 6ml 
of complete media (90% DMEM/F12, 10% FBS, 1% penicillin/streptomycin (10.000 
U/mL penicillin and 10mg/mL streptomycin), 0.1% amphotericin B (concentration 5 
µg/mL) and ascorbic acid (concentration 25µg/mL)) per 6 slices.  
To prove that the infection was successful, the cells were observed in the CLSM on the 
second, third and fifth day after transduction. 
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3.6.2.3 GFP-Lentivirus vector  
Lentiviruses are a generic group belonging to the family of the retroviridae. Their name 
comes from the Latin word lentus, which means slow and was used because the period 
between infection and outbreak of the disease can take time. Lentiviruses are present in 
ungulates, such as horses, cattle, sheep and goats, as well as in felids and primates64. 
Unlike the other retroviridae, lentiviruses can regulate their genes by themselves. 
However, they do not have a “correction system”, therefore mutations occur quite often. 
The probably most well-known lentivirus is HIV (Human Immunodeficiency Virus), 
which causes AIDS (Acquired Immunodeficiency Syndrome). In veterinary medicine the 
lentivirus is known for causing equine infectious anemia in equidae (EIA), as well as 
Maedi-Visna in small ruminants and feline immunodeficiency virus (FIV), which causes 
a similar syndrome in cats as AIDS in humans.  
They are enveloped, + RNA viruses, with a length of 7-12 kb65, which remain in their host 
during its lifetime. The virion has a diameter of 80-100 nm66.  
The three genes on the main segments are gag, pol and env, which code for proteins 
important for integration, replication and encapsulation of the virus66. There are further 
six genes, which also code proteins needed for replication, binding, infection and release 
(rev, tat, nef, vpr, vpu, Vif). Compared to conventional retroviral vectors based on 
Gammaretroviruses, the lentiviruses have the capability to infect non-dividing cells by 
overcoming the nuclear membrane67.  
 The only safety concern is, that there is a possibility of activation of cellular oncogenes 
of the provirus into the host genome68. In order to prohibit these negative aspects, a self-
inactivating expression vector (SIN) was used. This means, that a certain region (U3) was 
deleted to prevent the transcriptional activation of proto-oncogens67.  
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Figure 3.17. Lentiviral vector FUGW (source: Bruna de Andrade Pereira, PhD, Virology institute, 
Winterthurerstrasse 266a, 8057 Zürich, Switzerland). 
3.6.2.4 Infection with lentiviral vector 
In this study, we used the self-inactivating lentiviral vector FUGW (Flap-Ubiquitin-
promotor-GFP and WRE-Vector) in order to express GFP in the cells within our 
osteochondral tissues.  
After preparing the osteochondral explant slices they were placed in a 96 well plate with 
100µL of non-supplemented DMEM/F12. 40µL virus suspension was added per well.  
The virus titer was 1.6 x 107 gcp (genome-containing-particles) in 40µL. The samples 
were incubated for three hours at 37°C with 5% CO2 in a humidified standard cell culture 
incubator. Afterwards, the fluid was aspirated and the wells were filled with 200µL 
DMEM/F12 containing 10% penicillin/streptomycin (10.000 U/mL penicillin and 
10mg/mL streptomycin). The osteochondral slices were maintained in culture with a 
media change every second day. On the first, third and fifth day after the transduction, 
the cells were observed under the CLSM. 
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3.6.3 Cell labelling without viral vectors 
3.6.3.1 Membrane staining with 5-chloromethylfluorescein diacetate (CMFDA)  
Due to the uneasy handling of viral vectors, we decided to try out a membrane stain, 
which stains faster and lasts longer. For this stain, osteochondral plugs were harvested 
and cut into 300 µm slices by hand the same way as before.  
After taking the slices out of the complete media, they were washed in PBS on a shaker 
twice for each 5 min. Then they were put into a 24-well-plate (2 slices per well) with 
500µl DMEM/F12 media and 10µM of staining stock solution (= 1mg CMFDA in 215.1 
µl DMSO) was added. 
The covered well plate was wrapped in aluminum foil and incubated at 37°C, 5% CO2 for 
1,5 hours. Then the slices were taken out, washed in PBS twice for 5 minutes each, placed 
into complete media 90% DMEM/F12, 10% FBS, 1% penicillin/streptomycin (10.000 
U/mL penicillin and 10mg/mL streptomycin), 0.1% amphotericin B (concentration 5 
µg/mL) and ascorbic acid (concentration 25µg/mL). Slices were then imaged for 72 hours 
with the CLSM. 
The stain was bright and it was not clear if it only stained the membrane or the whole cell. 
Due to the 3D sample of 300 µm, staining may be overlapping in the layers and was 
difficult to distinguish in the CLSM. 
The stain lasted for a minimum of 14 days in culture. 
3.6.3.2 Membrane staining with CellTracker Blue 7-amino-4-chloromethylcoumarin 
(CMAC) Dye 2  
The idea behind using a blue stain was that one could lay a Live/Dead stain (green/red) 
over it. Like this we would have been able to prove if the blue stained cells were alive or 
not. With the CellTracker green CMFDA it was not possible to prove the viability of cells 
because one could not differentiate between the CMFDA green and the green of the live 
stain.  
In order to create a stock solution 5mg of CMAC dye was diluted in 2,385mL DMSO. 
10µM of this stock solution was then added to 500µL DMEM/F12 into a 24 well plate. 
Before this, the samples were washed twice in PBS for each 5 minutes on a shaker. The 
samples floating in staining media were wrapped up in aluminum foil to protect them 
from light and then incubated for 1,5h at 37 °C and 5% CO2. 
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After 1.5h the samples were imaged in complete media (90% DMEM/F12, 10% FBS, 1% 
penicillin/streptomycin (10.000 U/mL penicillin and 10mg/mL streptomycin, 0.1% 
amphotericin B (concentration 5 µg/mL) and ascorbic acid (concentration 25µg/mL)). 
The samples were kept alive for up to four weeks; in this time period the stain was stable. 
3.6.3.3 Live Cytoskeleton staining with SiR Actin  
When cells proliferate or migrate the actin skeleton changes its structure. With this stain, 
it was possible to make these changes visible, as it is based on the natural product 
jasplakinolide, which binds F-actin.  
In order to create a stock solution with the concentration of 1 mM, the 50nMol of SiR 
Actin stain were diluted in 50µL DMSO. For time-lapse experiments a constant 
concentration of 100 nM was needed during the whole experiment. To reach this 
concentration 0.1 µL of stock solution need to be added per mL of complete culture media 
(90% DMEM/F12 (catalogue no. D8437, Sigma-Aldrich), 10% FBS (catalogue no. 
10270106, Gibco), 1% penicillin/streptomycin (10.000 U/mL penicillin and 10mg/mL 
streptomycin; Sigma-Aldrich P4333), 0.1% amphotericin B (concentration 5 µg/mL, 
catalogue no. A4888, Sigma-Aldrich) and ascorbic acid (concentration 25µg/mL)). 
3.6.4 Cell viability staining 
Ingredients for Live/Dead staining Amount in % 
DMEM/F12 89 
FBS 10 
Penicillin/streptomycin, 100x stock:  
 (100 U/ml penicillin, 10μg/ml streptomycin) 1 
Amphotericin b, 1000x stock (5μg/ml) 
Only used on day 0-day 7 
 
0.1 
Calcein AM, 4mM in DMSO 0.1 
Ethidium-homodimer-1, 2mM in DMSO 0.1 
Table 3.5. Live/Dead stain working solution. 
 
In order to determine cell viability within the explants, the LIVE/DEAD® Cell Viability 
Assay Kit (Calcein AM 40µL, 4mM in DMSO, Ethidium homodimer-1, 200µL, 2mM in 
DMSO) was used. The living cells are stained green, the dead ones red. 
At first the staining media was prepared. For 300µL in total, 270µL DMEM/F12, 30µL 
FBS, 3 µL amphotericin B are mixed. 0.1% calcein AM and ethidium homodimer-1 were 
added in the end. The tube needed to be covered in aluminum foil immediately to protect 
the staining media from light. Then the samples were put in a 48-well-plate and 300µl of 
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staining media was added per well and sample. The samples were then incubated at 37°C, 
5% CO2 for 2 hours and kept in the dark as much as possible. 
After two hours, the samples were taken out of the staining media and put into wells with 
PBS. The well plate needed to stay covered with aluminum foil to protect the samples 
from light, until they were imaged. When using the CLSM, the samples had to be placed 
in a suitable glass-bottom-dish to image them. 
Lentiviral vector CMFDA SiR Actin AAV vector 
- GFP Transgene 
- Retrovirus 
- Requires BSL 2 
- Green 
- Membrane 
stain 
- Red 
- Stains live actin 
fibers 
- GFP transgene 
- Parvovirus 
- Replication deficient 
Table 3.6. Cell Labels summary of Characteristics. 
3.7 Time-Lapse with Confocal Laser Scanning Microscopy 
3.7.1 List of Materials 
3.7.1.1 Chemicals and Reagents 
• Agarose-gel, low temperature gelling (Catalogue no. A9045, Sigma-Aldrich 
Chemie GmbH, Buchs, Switzerland) 
• Phosphate buffered saline (Catalogue no. 10010015, Life Technologies Europe 
B.V., Zug, Switzerland) 
3.7.1.2 Instruments 
• Confocal laser scanning microscope SP5 UV-VIS (Leica, Solms, Germany) 
3.7.1.3 Other Consumables 
• Glass-Bottom-Well plates (Catalogue no. P06-1.5H-N, Cellvis/BL Baustoff & 
Labor, 2201 Gerasdorf near Vienna) 
• Serlim Wellinserts (Designed by Salim E. Darwiche, PhD, and Serah N. Saitowitz 
and built by Reto Maier, Physics Institute, UZH Zurich, Switzerland) 
• Serological pipettes (2; 10; 25; 50ml), (Catalogue no. 2mL, 86.1252.025, 10mL 
86.1254.001, 25mL 86.1685.020, 50mL 86.1689.001 Sarstedt, Nümbrecht, 
Germany) 
• 16G x 1” Needles (Catalogue no. 4710016025, Henke-Sass, Tuttlingen, Germany) 
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3.7.2 Mounting of live explants in agarose 
In order to take a time-lapse recording with the CLSM, and to track single cells in a 
sample, the osteochondral slice needed to stay in one place, so it does not move and 
influence the results of tracking. Developing half-moon shaped stainless steel well insert 
pieces made it possible to not only divide the well into two but also fix the sample to the 
plate with agarose.  
Additionally, the agarose makes it more difficult for the cells to migrate out of the tissue 
and a separate stimulation from either cartilage or bone side can be reached. 
After adding the low-gelling temperature agarose powder to sterile PBS in a beaker glass, 
it was carefully heated in a microwave under supervision, so it would not boil.  
4% Agarose gel 
(1g Agarose was diluted in 25mL PBS) 
Table 3.7. Agarose gel solution. 
The 4% low-gelling temperature agarose (mixed with PBS) was cooled down to 37°C 
under the hood while constantly monitoring the temperature with a digital thermometer. 
Then it was filled into the wells containing the sample and the stainless-steel pieces with 
a sterile syringe and a 16 Gauge needle. After about 3 minutes the fluid agarose gelled. 
Then the stainless-steel pieces were removed and media could be filled into the well. 
  
Figure 3.18. Serlim Wellinserts. 
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3.7.2.1 Agarose Test 1 
The first Agarose well, was basically just a simple wall created through two Serlim 
Wellinserts the size of half the well. Here we used 12 well plates. Through using special 
low temperature gelling Agarose, covering harmed none of the cells69. We used 3% and 
4% Agarose with PBS and filled it into the well right after the Serlim Wellinserts were 
placed in the plate with a syringe and a 16 G needle with a flow rate of 128 mL/min. The 
slice was covered at first in order to prevent the slice from floating up and letting Agarose 
get in between the glass bottom and the slice.  
 
 
I 
II 
Figure 3.19: Well with two large Serlim Wellinserts, spaces filled with agarose, which 
then create two separated wells (I & II). 
Material and methods 
47 
3.7.2.2 Agarose Test 2 
Here the Serlim Wellinserts were shifted and put in a six well plate. We used 4% Agarose 
to strengthen the stability not only through increasing the amount of agarose but also the 
thickness of the wall.  
 
 
 
 
 
 
 
 
 
 
I 
II 
Figure 3.20. Glass bottom six well plate with Serlim Wellinserts. 
Figure 3.21. Agarose well with two separate chambers ( I & II). 
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3.7.2.3 Agarose Test 3 
To prevent the agarose from floating up in media and rotating within the well, we 
embedded additional stainless steel cylinders with a diameter of 2 mm and a length of  
12 mm.  We chose to embed 4 cylinders per well.  
 
 
Figure 3.22. Agarose well with inserted cylinders to weigh down the gelled agarose. 
 
3.7.3 Confocal Laser Scanning Microscope 
Using a Confocal Laser Scanning Microscope (CLSM) made it possible to image the 
samples over a longer time-period. This microscope has a built-in incubator, which made 
it possible to keep the perfect temperature, humidity and CO2-concentration constant 
while the samples were under the microscope. Only because of this it was possible to do 
the time-lapse recording. To produce optical sections through a three-dimensional 
sample, the CLSM is perfect70. The confocal laser-scanning microscope (CLSM SP5 UV-
Vis) which was used, is located at the Zentrum für Mikroskopie und Bildgebung (ZMB), 
Irchel Campus UZH. The lasers can handle the depth of each slice much better than any 
other available microscope at the UZH. 
Besides that, it is inverted and makes it possible to image the samples, which are placed 
on the bottom of the well plate, without having to go through all the layers of agarose. 
Like this there is nothing in between the laser and the sample, besides the glass bottom of 
the well plate. In order to reconstruct the three-dimensional sample and also to track 
possible cell movement through different layers, the z-stack imaging was very useful. 
3.7.4 Time-lapse setup 
To track the cells within a sample, the cells are stained and placed in the Agarose wells 
described in chapter 3.6.1.2. The six-well plate can be placed in the microscope with help 
I 
   II 
2mm 
12 mm 
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of a multi-well plate-insert. It is then covered with a special lid, which is connected to the 
CO2. The temperature is set at 37°C and the CO2 at 5%, so the cells can be imaged under 
the same conditions as within an incubator at the laboratory. Because there is no water 
basin in the microscope, a petri dish with a diameter of 200 mm was placed in the 
„incubator” and filled with distilled H2O, to keep the humidity conditions upright. The 
distilled H2O had to be refilled every day. 
Depending on the stain that was used for the cells, the lasers are set (Table 3.8). 
The bright field channel was also always used, so that the background tissue with the 
different cartilage layers was visible, to have better orientation while tracking the single 
cells. 
Stain Laser Setting of Laser 
Actin-stain HyD4 633 nm at ca. 4% 
CMFDA-stain HyD2 488 nm at ca. 4% 
Live stain HyD2 488 nm at ca. 4% 
Dead stain HyD4 561 nm at ca. 8% 
Table 3.8. Laser settings according to stain. 
Before the time-lapse was started, multiple positions were set for each well. For each 
position, z-stacks were chosen and saved. Then the duration of the time-lapse, as well as 
the time interval was set. The total duration of a time lapse was set for 72 hours, with a 
time interval of 1 hour. The samples were all imaged with a dry objective that has a 
magnification of 10x. The resolution was set at 12 bit. 
 
Figure 3.23. Confocal Laser Scanning Microscope SP5 at the ZMB, University of Zurich, Switzerland. 
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4 Results 
4.1 In Vitro Explant Culture 
4.1.1 Explant harvest and culture 
The explant harvest and culture procedures were successful. Although the harvest 
procedure was done ex vivo, no microbiological contamination was observed. The 
washing procedure with antibiotics in PBS was therefore successful in preventing 
contamination throughout the in vitro experiments (manipulation, culture, time-lapse).  
The method of harvesting plugs and producing thin osteochondral slices, although done 
manually, was consistently successful throughout the experiments across multiple 
harvests. This method, first established by Dr. med. vet. Sophie Schöberl1, was 
successfully transferred and adapted to the experiments described in this thesis. This 
showed that the methodology was repeatable and successful also with different operators.  
The cells within the explants were viable after osteochondral sample harvest and 
throughout the culture period (up to 8 weeks). This was also the case when slices were 
produced from individual plugs, which showed that the designed growth media was 
compatible with osteochondral explant culture maintenance with media changes 2-3 times 
weekly. The culture conditions were appropriate for both osteochondral plugs and slices.  
4.1.2 Sample mounting in Agarose wells 
In order to image the cells within the explants over 72 hours it was most important to 
keep the sample immobilized and to prevent the flotation of the slices in its media during 
imaging. As described in methods, first, the osteochondral slice (200-300 µm) was fixed 
with a simple agarose wall, which went diagonally once across the well (35 mm in 
diameter). We were able to create this with the help of large Serlim Wellinserts. However, 
after removing the Serlim Wellinserts, the remaining slim agarose wall collapsed easily 
or floated and then tipped over when adding media. A thicker, 4% agarose (instead of 
3%) was used to create more stability. This was not enough though because the wall 
would still wobble sideways, despite the thicker agarose. By using smaller inserts, and 
placing them in such a way to shorten the wall between both agarose wells, the stability 
was increased and the osteochondral slice would be placed within the wall (Figure 3.21).  
To keep the whole agarose structure from rotating within the 35mm well, stainless steel 
cylinders were embedded in the agarose to weigh down the agarose structure  
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(Figure 3.22). But these cylinders where not heavy enough and would easily escape the 
agarose after some days. Using sandpaper, the slick walls of each well plate could easily 
be roughened. This increased the friction between the agarose structure and the 35mm 
plastic well walls, thereby avoiding agarose rotation, even when the agarose was swollen 
with media, which usually would make it more slippery.  
Because the heated agarose cooled down very quickly, keeping it at the perfect 
temperature while making the agarose wells was challenging. The agarose was poured 
into the well at 34-39°C, to avoid causing harm to the explants or cells within. With the 
help of a digital thermometer, it was easy to control the temperature. Many osteochondral 
slices were mounted in an agarose structure throughout experiments described herein, and 
cell viability was not impacted by the agarose gelling procedure, even at temperatures 
reaching 39°C. 
Imaging was sometimes impaired if the osteochondral slices, which were cut by hand, 
were not flat enough to lay homogenously against the glass bottom surface. Indeed, if 
different thicknesses of agarose were present between the sample and the glass, this 
negatively impacted the imaging quality. 
Finally, it was possible to reliably label cells within osteochondral slices, while the slices 
were embedded within the agarose structure. This allowed us to first embed the sample 
within the agarose, acclimatize the sample to the new diffusion microenvironment, and 
label the samples thereafter. The procedure of mounting, culturing and labeling was 
therefore successfully performed throughout the experiments. 
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4.2 Cell Labelling 
4.2.1 Lentiviral vector cell labelling 
Using a lentiviral vector to label cells with GFP, the fluorescence in the cells started 
increasing on day three, post infection. On day five post infection it was very bright 
(Figure 4.1) and sustained for at least a month. The signal was also sustained after 
thawing, following explant freezing at -20°C. The cells in explants, including the calcified 
cartilage, deep zone and subchondral bone, were transduced, as they exhibited a visible 
GFP signal.  
Staining for viability after transduction did not reveal more dead cells than before 
transduction. This proved that the infection itself did not cause detectable cell death 
within the explants. 
 
Figure 4.1. Labelling with Lentiviral vector 5 days post transduction (source 1). 
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4.2.2 AAV vector cell labelling 
With an AAV vector, it took up to three days for the GFP transgene to appear. The GFP 
transgene signal was brightest at day 3 (Figure 4.2) and fading thereafter. After about 7 
days following transduction, no GFP-signal was visible in the explant samples anymore. 
The fluorescence was not as bright as with the lentiviral transgene, even when the dosage 
of AAV was increased. The whole cell appeared fluorescent, indicating that GFP was 
spread throughout the cell, but it was difficult to distinguish in a 3D sample. Also, with 
this method of labelling, mostly cells in the subchondral bone, the calcified cartilage and 
the deep zone were transduced. As with the Lentiviral infection, AAV infection did not 
affect the viability of cells. 
 
Figure 4.2. Labelling with AAV-vector 3 days post transduction (source 1). 
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4.2.3 CMFDA cell labelling 
Using the CMFDA cell-membrane labelling, the fluorescent signal was very bright. That 
was already the case immediately after staining, as is expected when using a passive stain. 
It was not clear whether the label was localized in the cell membranes only or labelling 
the whole cell, mainly due to technical limitations with 3D imaging with the CLSM. The 
stain lasted for a minimum of 14 days in culture and did not have an effect on the viability 
of cells within explants. In order to label cells within the subchondral bone, the labelling 
agent would have to penetrate through the bone tissue, which is more challenging than 
water-filled tissues such as cartilage. By extending the labelling step in the protocol to  
24 hours (compared with 40 minutes using the standard protocol), it was also possible to 
visualize the subchondral bone cells within explants.  
 
Figure 4.3. Labelling of cells in an osteochondral slice with CMFDA membrane stain. 
4.2.4 CMAC Blue cell labelling 
This label was chosen in order to explore the possibilities to create multiplex imaging, 
using for example the Live/Dead labelling as well as a passive membrane stain. The 
handling of this passive membrane stain was as simple as the CMFDA. Unfortunately, 
the imaging of cells within the blue emission spectrum was not as good as with the green 
wavelengths. Indeed, the signal was very weak, especially in 3D tissues. Because of this, 
this label was not explored any further. 
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4.2.5 SiR Actin cell labelling 
The active SiR Actin cytoskeleton label was very easy to handle. A positive signal 
indicated both the cell viability as well as active changes in the cytoskeleton. The labeling 
technique was very reliable and was successful both with free floating samples as well as 
agarose-embedded samples. After a longer staining procedure, this label also showed the 
cells in the subchondral bone very clearly. However, the SiR Actin label had to be present 
in the culture media throughout the experiment, in constant contact with the explants, 
which may have caused unknown side effects as well as a high usage of the label.  
4.2.6 Summary of findings and choice of label for time-lapse experiments 
After trying different methods of staining, the AAV was not the first choice, because the 
transduction took time, was not reliable and the GFP expression disappeared in 7 days. 
The lentivirus vector worked better, labelling the cells intensively and lasting for much 
longer. Still, the whole transduction procedure was quite complicated, mainly due to 
biosafety requirements. Indeed, the explant samples had to be carefully transported to the 
virology institute, transduced, then transported back to the CABMM laboratory for 
further processing.  
As for the passive membrane label CMFDA CellTracker, it was very easy to handle 
compared to the viral vectors, and it took only 40 minutes to label the cells, which then 
exhibited the fluorescent signal immediately after the labeling procedure. In addition, the 
stain was as visible and long lasting as the lentivirus vector. The CellTracker CMAC Blue 
was as easy to handle as the CMFDA. Its labelling capability was equivalent, as visible 
by eye, but was difficult to image at this wavelength in a 3D sample.  
The SiR Actin live label, the fluorescent signal was very reliable, worked well, especially 
in time-lapse experiments and as a great advantage could be combined with other stains 
as well (the emission spectrum did not overlap with the standard green emission of the 
Live stain, for example). 
Therefore, given the various pros and cons of the labelling methods tested, the SiR Actin 
was chosen to image samples for further experiments described in this thesis. 
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4.3 LPS stimulation in vitro with healthy explants 
Using healthy osteochondral explants from the shoulder joint of sheep sacrificed for other 
experiments, a stimulation of the explants in vitro was attempted using LPS. First, a dose 
titration was achieved to find the maximal dosage not causing cell death.  Thereafter, the 
stimulation experiment was performed.  
4.3.1 LPS dosage and explant viability 
Using 2 µg/mL LPS in growth media was a too high dosage, as it killed most of the cells 
in the explant after 24 hours as well as after 48 hours, as seen in Figure 4.4. 
 
Figure 4.4. Live/Dead staining after 24-hour (left) and 48-hour (right) stimulation with 2µg/mL of LPS. 
Using 1 µg/mL LPS, cell death did not occur and there were many viable cells and no 
more dead cells than what is normally observed in control samples (unstimulated). No 
visible changes were detected within the first 24 hours (Figure 4.5). After 48 and 72 hours, 
however, some cluster formation was already visible following LPS stimulation  
(Figure 4.6). This confirmed that the dose of 1 µg/mL LPS was sufficient enough to cause 
a cellular effect, but not too high to cause cell death. Therefore, this dose was used in the 
following LPS-stimulation time-lapse experiment. 
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Figure 4.5. Live/Dead staining of stimulated explants with 1µL LPS/mL media after 24hours,  
showing no changes in cell order and viability. 
 
Figure 4.6. Live/Dead staining of stimulated explants with 1µg/mL LPS after 72hours,  
showing clear cluster formation but hardly dead cells. 
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4.3.2 Timelapse after LPS stimulation 
 
Figure 4.7. Snapshots (Frame 1 through 6)  from Group 1 sample time-lapse (10-13 days pre-culture, 7 day 
LPS stimulation), showing a cell (highlighted in the white frame) from the subchondral bone (SCB) crossing 
into the calcified cartilage layer (RZ). TZ indicates Transition zone, RZ indicates Radial zone, SCB indicates 
Subchondral bone zone. The scale bars indicate 50 µm. 
While comparing the results of the groups listed in Table 3.4, the highest activity was 
observed in groups in which explants were cultured for 10-13 days after harvesting. The 
activity was clearly detectable regardless whether samples were stimulated with LPS or 
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not. Activity was defined as detected migration behavior and possible proliferation. Both 
migration from subchondral bone into the overlying articular cartilage as well as 
migration and suspected proliferation within the cartilage tissue were detected. The LPS 
group samples, especially the ones with 7 day LPS stimulation, appear to show higher 
cell activity, however, this was not quantitatively or qualitatively confirmed. 
4.4 Imaging of In vivo Experiment Explants 
Explant samples taken from the two treatment groups were processed in order to perform 
confocal imaging to detect the Live/Dead labelling as well as time-lapse imaging to detect 
cell activity, with cells labeled with SiR Actin.  
4.4.1 Control Group 
The cartilage harvested from the control group animals was expected to show signs of 
degeneration, as no treatment was applied, following the metaphyseal tibial defect 
creation, which is known to cause apposing cartilage degeneration. The degeneration was 
expected to appear directly above the metaphyseal defect area, whereas the cartilage from 
surrounding areas was expected to be unaffected. The bordering cartilage may exhibit 
degenerative effects as well, but not as severe as those above the defect zone. 
4.4.1.1 Viability test 
After harvesting and washing the plugs, a viability check was first performed with a 
simple LIVE/DEAD staining. Slices were chosen from a plug that was harvested in the 
defect region. Slices were also chosen from a plug taken on the border of the defect, which 
had an “in-defect” and a “non-defect” part.  
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Figure 4.8. Live/Dead staining of control sample harvested above metaphyseal defect, as shown in the 
schematic on the right. SZ indicates Superficial Zone, TZ indicates Transition zone, RZ indicates Radial zone, 
SCB indicates Subchondral bone zone. The scale bars indicate 150 µm. 
 
In the samples taken from the defect area, hardly any live cells (green in Figure 4.8) were 
seen in the subchondral bone, but also very few dead cells (stained red) were seen, 
indicating that no cells were present in that zone, due to the underlying defect. This could 
be due to cells migrating out of this area or that cells had died and that DNA was washed 
(or digested) away at an earlier timepoint in vivo, prior to sample harvest. The cells in the 
transition zone and radial zone were alive, with few dead cells. However, many dead cells 
were detected in the superficial zone, possibly indicating the degrading health of the 
cartilage tissue as a whole, in this area above the defect. 
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Figure 4.9. Live/Dead staining of control sample harvested on the border, above-defect side, as shown in the 
schematic on the right. SZ indicates Superficial Zone, TZ indicates Transition zone, RZ indicates Radial zone, 
SCB indicates Subchondral bone zone. The scale bars indicate 150 µm. 
 
In Figure 4.9 samples taken above the defect area, but on the border of that region, hardly 
any live cells were observed in the subchondral bone. In this case, however, dead cells 
were observed in that zone, unlike in Figure 4.8. Regarding the cells in the cartilage layer, 
about 30% seemed to be dead, with increasing amounts closer to the superficial zone, but 
less so, however, than in the defect area as in Figure 4.8.  
On the “non-defect-side”, as seen in Figure 4.10, cells in the subchondral bone were all 
dead except for very few live ones. However, the cartilage zones looked very viable and 
hardly showed any dead cells. This was in stark difference to what was observed in  
Figure 4.8 and in Figure 4.9 and went in line with the expectation that the cartilage tissue 
above the defect area would exhibit degeneration, but not in areas where there was no 
underlying bone defect. 
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Figure 4.10. Live/Dead staining of control sample harvested on the border, non-defect side, as shown in the 
schematic on the right. SZ indicates Superficial Zone, TZ indicates Transition zone, RZ indicates Radial zone, 
SCB indicates Subchondral bone zone. The scale bars indicate 150 µm. 
4.4.1.2 Time-lapse 
Even though few cells were detected in the subchondral bone using the viability assay, a 
notable number of cells was detected through the time-lapse imaging of SiR Actin 
labelled cells. This may be due to the SiR Actin label diffusing differently within bone 
than the viability assay labels. While no clear migration of cells from subchondral bone 
into the overlying hyaline cartilage could be noted within the time frame of 72 hours, 
subchondral bone cells nevertheless did not remain static in the frame of view. Instead, 
the visible cells in the subchondral bone seemed to move in the z-axis, coming into the 
frame of view (Frame 2 of Figure 4.11) and then back out (Frame 4 of Figure 4.11). 
Furthermore, the labelled subchondral bone cells seemed to aggregate in clumps in the 
subchondral bone tissue, which may be an indication of abnormal behavior for these cells. 
As for cells within the cartilage zones, few were detectable in the time-lapse. This was 
likely a combination of technical imaging difficulties and the presence of many dead cells 
within the cartilage layer, as shown in the viability assay of such samples. This combined 
challenge made it difficult to evaluate any changes within cartilage cell populations. 
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Figure 4.11. Serial snapshots (Frames 1 through 4) taken from the time-lapse of a control-group (untreated with 
Diclofenac) sample. Cells were labelled ex-vivo with SiR Actin. TZ indicates Transition zone, RZ indicates 
Radial zone, SCB indicates Subchondral bone zone. The scale bars indicate 100 µm. 
4.4.2 Diclofenac-treated Group 
The cartilage from the samples harvested from the Diclofenac-treated group was expected 
to benefit from the anti-inflammatory treatment, despite the metaphyseal defect creation.  
4.4.2.1 Viability test 
Viability assays were performed on the harvested osteochondral explants from sheep 
stifle joints, treated with Diclofenac every day for a total of 14 days through a TDA 
system. Slices taken from explants extracted within the defect area (Figure 4.12) showed 
few labelled cells in the subchondral bone. Some dead cells were detected in this layer. 
The cells in the cartilage layer, however, were very strongly labelled and were viable with 
only very few scattered dead cells. This was in contrast to control-group slices, in which 
superficial cartilage cells were not viable (Figure 4.8). The same pattern was observed on 
the edge of the defect, both with the “in-defect” half (Figure 4.13) and the “non-defect” 
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half (Figure 4.14). The “in-defect” half showed a few more dead cells and the live cell 
signal was overall weaker. 
4.4.2.2 Time-lapse 
The time-lapse imaging of Diclofenac-treated samples revealed the number and location 
of labelled cartilage cells was physiological. No clear changes were detectable in the 
cartilage layers throughout the time-lapse duration. In contrast, a great number of 
subchondral bone cells were detected and increase throughout the time-lapse imaging 
window. This indicated either a proliferation of subchondral bone cells or a migration of 
subchondral bone cells into the field of view or a combination. The discrepancy between 
the subchondral labelling in the viability assay and using the SiR Actin was further 
confirmed with the samples from the Diclofenac group. Subchondral bone cells did not 
form clumps or non-physiological aggregates, as in the control group, but instead seemed 
to migrate into the cartilage layer. The migration pattern was however not unidirectional. 
 
Figure 4.12. Live/Dead staining of Diclofenac-treatred sample harvested above metaphyseal defect, as shown in 
the schematic on the right. TZ indicates Transition zone, RZ indicates Radial zone, SCB indicates Subchondral 
bone zone. The scale bars indicate 150 µm. 
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Figure 4.13. Live/Dead staining of Diclofenac-treated sample harvested on the border, above-defect side, as 
shown in the schematic on the right. TZ indicates Transition zone, RZ indicates Radial zone, SCB indicates 
Subchondral bone zone. The scale bars indicate 150 µm. 
 
 
Figure 4.14. Live/Dead staining of Diclofenac-treated sample harvested on the border, non-defect side, as shown 
in the schematic on the right. TZ indicates Transition zone, RZ indicates Radial zone, SCB indicates 
Subchondral bone zone. The scale bars indicate 150 µm. 
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Figure 4.15. Serial snapshots (Frames 1 through 3) taken from the time-lapse of a Diclofenac-treated sample. 
Cells were labelled ex-vivo with SiR Actin. TZ indicates Transition zone, RZ indicates Radial zone, SCB 
indicates Subchondral bone zone. The scale bars indicate 100 µm. 
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5 Discussion 
In summary, this thesis describes the successful design of a functioning system to track 
cells in osteochondral explants of sheep in vitro.  
With this technique, the microenvironment of the cells was successfully maintained, even 
with cell labelling techniques used. We managed to stain cells in cartilage and bone tissue 
and proved that the cells were viable in the calcified layer. The described cell culture 
method made it possible to keep explant samples viable in culture for up to 8 weeks, both 
as slices and as whole osteochondral plugs. The osteochondral interface was therefore 
preserved in vitro and the cells in this region could then be observed and tracked over  
72 hours. Explants in culture could also be stimulated with soluble factors, simulating 
inflammation. Furthermore, it was also demonstrated that viral vectors using AAV and 
lentivirus could transfect cells in the subchondral and chondral part of the osteochondral 
slices. With all techniques it could be verified that cells of the calfied cartilage zone were 
viable and not hypertrophic. To the knowledge of the author, these findings were never 
reported in the literature.  
5.1 Agarose wells / osteochondral slices / culture 
The OATS technique of explant harvesting, as well as the processing and culture with the 
described media worked very well with no instances of contamination throughout the 
experiments.  
As for the immobilization technique with the agarose structures, roughening the well 
walls with sand paper was the most successful method to maintain the agarose structures 
static. However, square wells would completely prevent the movement of the agarose 
structures. Square wells were not commercially available and may need to be custom 
designed and produced for this purpose. 
As for the osteochondral slices, it was not always possible to guarantee that the samples 
lay flat on the glass-bottom of the well. That is because the explant slices were cut by 
hand and in consequence many were curved or uneven on a microscopic level. This could 
cause the agarose to penetrate between the sample and the glass-bottom, which changed 
the focus while imaging. Developing a standardized tool to slice the explants evenly 
would be ideal, in order to reliably create flat surface explant slices and slices of similar 
thicknesses. Such a cutting tool would, however, need to be very sharp in order to 
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preserve the viability of the cells within the explants. Indeed, blunt tools could easily 
crush the cells and compromise the viability of the samples during preparation. 
Finally, the agarose structure created here in order to immobilize the samples for imaging 
may still be vastly improved. For instance, the use of a different, biocompatible material 
may provide an advantage to agarose, especially if that new material is both stiffer and 
less permeable than agarose. Ideally, completely separating the chondral and bone parts 
would allow the exposure of both tissues to different growth media formulations with 
different stimulating factors simultaneously. This would better mimic the situation in the 
native tissue. 
5.2 Labels 
With the present study, we were able to develop techniques to label cells within 
osteochondral explants. Most cell labels are designed to be used on cell cultures or cell 
suspensions, and not on tissue cultures. Our experiments showed that osteochondral 
tissues, notoriously difficult to label because of the dense tissue structure, were 
successfully labelled using various methods. Furthermore, the osteochondral explants 
could be labelled while embedded in the agarose structure. 
As the aim of this thesis was to investigate migration of different cell types within the 
osteochondral tissue, having a cell-specific live label would have been ideal. However, 
there was no chondrocyte-specific or bone-cell specific live cell label available on the 
market. We therefore had to explore several techniques to label live cells within a tissue, 
regardless of the cell type. The label needed should not affect the viability of the tissue 
and should successfully label all cells in cartilage as well as in subchondral bone over a 
selected time period (at least 7 days).  
The CMFDA CellTracker green stain turned out to be a very “easy-to-do” stain, which 
colored the chondrocytes with great success. Being a passive membrane stain, it was not 
expected to interfere with any normal cell function. However, no matter how the protocol 
was modified, there was no way for it to stain the cells in subchondral bone. 
Both viral vectors worked in labelling cells throughout the explant slices. The lentivirus-
infected cells exhibited the GFP label 5 days after infection, while the AAV-infected cells 
exhibited the signal after 3 days but faded completely in the following 4 days. The AAV 
technique limited the signal intensity as well as the window of imaging to barely 72 hours. 
With both infection methods, it was not possible to verify the viability of the cells within 
the explants after GFP expression, or whether the GFP expression was sustained over 
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time, as opposed to GFP simply being deposited and the cells subsequently dying. This 
latter possibility was suspected after the GFP signal was detected following the freezing 
of samples at -20°C. In this case, the cells would not be expected to survive the freezing 
process, but the GFP signal was still visible. The link between a viable cell and a visible 
GFP signal was therefore not always verifiable. Having a transgene, which emits at a 
different wavelength than the viability stain, would be ideal. 
The SiR Actin stain was definitely the best option because it stained the cells localized in 
subchondral bone as well as in cartilage and additionally was able to show the dynamics 
of the cytoskeleton in each cell. This was not only an indirect proof of viability, but also 
showed how cells changed their skeleton in order to migrate. A negative aspect regarding 
this stain, was that it could possibly influence the cells over a long time period. Because 
it was necessary to include it in the standard culture media in order to maintain the signal, 
cytotoxicity may be possible, even if we could not detect it. The SiR Actin label was 
tested on human fibroblasts in culture, as described by the manufacturer, and no cytotoxic 
effect was observed within 24hours71. A study of how continuous SiR Actin exposure to 
cells within cultured tissues would be necessary to ensure no adverse effects.  
Finally, the viability assay label was a useful tool to verify the viability of the cells within 
the explants. However, this was only possible within the cartilage layer, as we suspected 
the diffusion of the label within the subchondral bone to be limited. The use of an 
alternative viability label, or an adapted penetration protocol, would be needed, especially 
in order to show the viability of the subchondral bone. 
Rating Lentiviral vector CMFDA SiR Actin AAV vector 
  + 
+ Long lasting 
+ Strong signal 
+ Quick and easy 
+ Bright 
+ Passive 
 
+ Easy 
+ Stains well 
+ Bone cells 
+ Stains viable 
cells only 
+ Safer than 
lentivirus 
+ Low risk of 
insertional 
mutagenesis 
_ 
- Uneasy handling 
- Safety (BSL2) 
- Risk of insertional 
mutagenesis 
- Cannot 
simultaneously check 
viability 
- No bone cells 
were stained 
- cannot 
simultaneously 
check viability 
- possible 
cytotoxicity 
 
 
- Uneasy handling 
- Fades after 7 
days 
- Not very bright 
Table 5.1. Positive and negative aspects of the used labelling methods. 
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5.3 Time-lapse 
The time-lapse experiments were performed to prove migration of cells from the 
subchondral bone tissue into the overlying hyaline articular cartilage. This was tested in 
healthy osteochondral explants from sheep cadavers as well as explants from sheep stifles 
following a surgical procedure, which is designed to compromise cartilage viability.  
In order to answer the scientific question, namely whether anti-inflammatory therapy 
stimulates cells within osteochondral tissues, the establishment of the imaging technology 
was needed. To that end, we were able to successfully maintain osteochondral explant 
slices in culture, embedded in agarose structures while labelling the cells within 
throughout an imaging period of 72 hours. This was achieved in various samples and the 
imaging protocol was adapted throughout the experiments to ensure the capture of 
labelled cells within the 3D tissue. This included the setup of automated z-stack imaging 
as well as automated pre-defined regions of interest across 12 different slices positioned 
in 6 different wells. After much adaptation, the samples were successfully immobilized 
throughout the imaging period. Imaging the fluorescent signal was combined with a 
brightfield image in order to identify the different layers of osteochondral tissue within 
each sample. However, despite the successful imaging, showing the migration of cells in 
explants still proved to be a technical challenge, which made the reliable comparison 
between treatments difficult to achieve. 
Due to the fact that the cell culture media needs to be changed every 72 hours in order to 
guarantee the viability, the duration of the time-lapses was also limited to 72 hours. If it 
were possible to somehow change the media during the time-lapse, perhaps in an 
automated way, and given the observed dynamics of the cells, imaging over twice the 
current time window would be recommended. A longer time frame is needed because the 
cells within a dense tissue structure such as the osteochondral tissue likely require a longer 
time to migrate than cells on tissue culture plastic. In addition, due to the very dense tissue 
composition, cells would move very slowly, which is the reason why the interval of 
recordings should not be less than 1 hour. This creates an advantage when imaging of 
multiple days because it reduces the imaging file size and the exposure of the samples to 
the laser. Different labelling methods would react differently to laser exposure, with 
CMFDA being the most vulnerable to bleaching because it is a passive membrane stain. 
The SiR Actin would only be mildly affected by bleaching as it is continuously present 
in the media in an inactive form. Finally, the method using expressed transgenes 
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(Lentivirus or AAV infection), would be the least affected, because “fresh” GFP is 
constantly produced by the cells.  
In all time-lapse recordings, a clear activity and cell movement was shown in the 
subchondral bone, especially in the Diclofenac-treated group. This was also the case in 
the cartilage layers where more activity was visible in samples treated with LPS. In this 
case, a directional movement from subchondral bone into the above lying cartilage could 
be detected. This also showed that the believed impenetrable border between subchondral 
bone and cartilage could be penetrable and that these two tissues would be able to 
communicate. From a theoretical point of view, there is evidence supporting this 
observation, especially when taking into account the vessels reaching into the calcified 
cartilage layer from the subchondral bone. Previous studies have also shown there is a 
clear change in subchondral bone due to cartilage defects or degeneration. A “cross-talk” 
has been clearly described between these adjacent tissues. 
Based on our experimental evidence, it is not yet clear if all the cells move within the 
sample, if only a subset of cells move, or if the movement has a preferential direction. In 
the case of the Diclofenac-treated sample, in which a high cell movement and activity 
was observed, the cells may have in fact migrated out of the tissue and may have been 
proliferating outside the explant. Because imaging the 3D tissue was challenging, it was 
not possible to determine where the cells were migrating in relation to the sample edge. 
Still we could prove the viability of these cells and the cells in the deep and calcified 
cartilage layer.  
5.4 In vitro inflammatory challenge 
In order to give the cells a “reason” to migrate or proliferate we decided to add 
inflammatory factors to stimulate them through the cell culture media. LPS is one of the 
most effective endotoxins inducing inflammation. LPS is often used in research and, 
depending on the dosage, it is either cell toxic or stimulating regarding cell proliferation60. 
We determined a not cytotoxic dosage before setting up the experiment. We also quickly 
realized that it would take more than 24 hours to cause an effect, such as movement or 
proliferation. This could be because of the dense tissue we were working with or because 
of the cell type or both. Based on our experimental evidence, the highest effect was visible 
after a 4 to 7 day LPS stimulation. 
LPS has been described to accelerate changes within cultured tissues. An additional 
stimulation with other inflammatory factors (e.g. TNF-α or Il-1-β) or a cocktail would be 
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interesting to investigate as well. It is not yet known what would be the ideal stimulant, 
which would create an inflammatory situation in vitro around a osteochondral explant. 
5.5 In vivo experiments 
Regarding the viability tests in the control group, a subchondral bone defect clearly had 
an influence on cell viability in the cartilage layers, as well as on the surrounding 
subchondral bone cells. The cartilage cells above the defect were much less viable than 
ones outside the defect, although these cells would likely degenerate sooner or later as 
well, because the cells in subchondral bone were mostly dead.  
The technology developed in this thesis could be used to answer the question why 
cartilage, e.g. in patients with osteoarthritis, does not remodel. In controls without any 
treatment after setting the defect, the overlying cartilage is severely degenerated already 
after 14 days. In the group that was treated with Diclofenac the overlying cartilage was 
less degenerated and more viable cells were visible, even though cells in the subchondral 
bone were dead. It may be speculated that, in this case, the cartilage overlying the 
subchondral bone defect was protected, on one hand through increased proliferation of 
chondrocytes due to oxygen application and, on the other hand, degeneration of cartilage 
was decelerated by the TDA treatment with Diclofenac. The latter is a non-steroidal anti-
inflammatory drug that is known to decrease the activity of matrix metalloproteinases, 
which are responsible for matrix degeneration. If the cartilage can be protected and 
homeostasis maintained through a balance of proliferation and degeneration, cartilage 
may have the ability to remodel. Results of the Diclofenac group in comparison to the 
untreated control group suggest this possibility.  
Perhaps there was no visible migration from subchondral bone into the cartilage layer 
because the cells, which usually migrate (namely, the stem cells), seem to be absent due 
to the created bone defect. It seems that in this short postsurgical period the cells within 
the subchondral bone could not recuperate yet. In another study of our group using the 
same animal model, it was demonstrated that the incorporation of intravital fluorescence 
dye was severely hampered in the subchondral bone area within the first month after 
creating the defect in the subchondral bone (publication in preparation: doctorate thesis 
Joya Kaserer). Therefore, if the in-life period were longer than 14 days post-surgery, the 
cartilage degeneration would likely proceed and the tissue would completely degenerate 
and cause osteoarthritis. This may be an explanation why the hyaline cartilage 
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consistently degenerates after fractures of the tibia plateau, although perfect alignment of 
the fragments was achieved during fracture repair.  
The notably viable cartilage cells in the Diclofenac group samples suggest that the anti-
inflammatory Diclofenac protected the cartilage with the help of oxygen and deceleration 
of the cartilage degeneration. This was the case even though the subchondral bone could 
not remodel. Theoretically the cells, which would migrate into the affected cartilage area, 
would have to come from adjacent tissue, because the cells in the defect area were 
damaged in surgery. The Diclofenac-treated cartilage, in comparison to the untreated 
control group, was clearly more viable. It is very possible that the migration process 
increases if Diclofenac treatments were administered longer than 14 days post-surgery. 
5.6 Conclusion and Perspectives 
Creating the first functioning system, which allows to track cells in an osteochondral 
explant tissue culture, describing bone and cartilage as a unit, is an immense progress in 
cartilage research. There are endless amounts of research done on bone and cartilage as 
two separate systems, but in the least cases they are looked at as one unit, although their 
origin and development is the same or very similar. We were able to not only look at the 
tissue as a unit, but also track the cells within while maintaining their microenvironments. 
There may still be technical improvements to achieve, but the described findings in this 
thesis mark an important step towards osteochondral cell imaging. 
The time-lapse experiments have clearly shown migration of cells to be possible, 
especially from the subchondral bone layer into the calcified cartilage layer. While the 
differences between treatment groups could not be clearly described due to technical 
limitations and variability, the developed system is a powerful method to investigate 
osteochondral tissue migration. Furthermore, the imaging experiments showed that cells 
in the calcified layer and transition zone, often assumed to be hypertrophic and terminal, 
were in fact viable and often active.  
Further development of this system could be used to reliably prove that cells migrate 
between these bone and cartilage. Any defect caused to the subchondral bone layer could 
therefore be linked, on a cellular level, to a degeneration of the overlying cartilage. This 
would be an additional proof that cartilage and bone act as one unit.  
Regarding the migration, it is still unknown how the cells free their path in order to 
migrate within this dense tissue. Would they have macrophage-like characteristics, or 
would they break down the tissue and leave by-products? If so, it is questionable what 
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would happen with the accruing by-products? Also affecting the overall integrity of the 
tissue would be possible. Are the cells capable of creating their surrounding tissue after 
“digging” their way to the cartilage layer with help of the by-products, or do they just 
leave a hollow space behind?  
What is also not known is what kind of cells would respond to stimulation: mesenchymal 
stem cells, which hypothetically differentiate after migrating through the calcified 
cartilage zone into chondroblasts, resp. chondrocytes? Future studies should definitely 
address these issues.  
Finally, one must not forget that these studies were performed in a sheep model. Although 
not exactly identical with human cartilage, the basic morphology of sheep is very similar 
in human beings. Therefore, it may be safely assumed that the basic mechanisms of 
cartilage remodeling in sheep and humans are similar and much can be extrapolated from 
these findings. 
There are still a lot of unturned stones on the long research-path of cartilage remodeling. 
But, this work gives us a first stepping stone into the right direction, with a new powerful 
tool of investigation. Proving that cartilage is supplied with cells from the subchondral 
bone also in healthy hyaline cartilage would be revolutionary and an important discovery 
for the future of medicine. It may not only change future therapy of cartilage defects, but 
also could influence measures of preventing osteoarthritis. 
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7 List of Abbreviations  
 
CLSM  Confocal Laser Microscope 
HBSS  Hank`s Balanced Salt Solution 
PBS  Phosphate-Buffered Saline 
FBS Fetal Bovine Serum 
OATS  Osteochondral Autograft Transfer System 
DMEM  Dulbecco`s Modified Eagle Medium 
LPS  Lipopolysaccharides from Escherichia coli 
TNF α Tumor Necrosis Factor α 
IL1ß  Interleukin-1-ß 
GFP Green Fluorescence Protein 
PCV   Packed Cell Volume 
MCH Mean Corpuscular Hemoglobin 
MCHC Mean Copuscular Hemoglobin Volume 
MCV  Mean Copuscular Volume 
RBC Red Blood Cells 
WBC White Blood Cells 
GOT/ASAT Glutamyl Oxaloacetic Transaminase / Aspartate Amino 
Transferase  
GGT Gamma-Glutamyltranspeptidase 
CK Creatine Kinase 
Na Sodium 
K Potassium 
Cl Chloride 
Ca Calcium 
Mg Magnesium 
3D Three-dimensional 
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